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A NOVEL ANATOMICAL LUNG PHANTOM AND ITS
APPLICATIONS IN LUNG PERFUSION SCANS FOR
PULMONARY EMBOLISM DIAGNOSIS

Norlaili A. Kabir

A Thesis for Doctor of Philosophy
Centre for Medical Radiation Physics, Engineering Physics
University of Wollongong

Abstract
Numerous commercial and non-commercial nuclear medicine imaging
phantoms are used for quality assurance studies, teaching, training, and
research. Commercially available phantoms are sometimes not applicable
in specific medical studies. As non-commercial phantoms are not easily
accessible, many researchers have chosen to construct their own distinct
phantom. This thesis describes the design, development and characteristics
of a novel anatomical lung phantom. The phantom was uniquely developed
to model perfusion conditions of patients with suspected pulmonary emboli.
Two imaging modalities were chosen in this study: planar imaging and
Single Photon Emission Computed Tomography (SPECT) imaging.
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Applications of the phantom as a quality assurance (QA) device and as a
training and teaching tool were studied. The phantom was used as a QA
tool to compare the interpretations of Nuclear Medicine physicians on lung
perfusion

and

ventilations

scans

using

the

revised

Prospective

Investigation of Pulmonary Embolism Diagnosis (PIOPED) criteria. The
studies showed both the correct and incorrect diagnosis of pulmonary
embolism by the physicians.

A comprehensive lung perfusion imaging

atlas is also included in the thesis. A close ended Likert-scale survey was
carried out to study the significance of the imaging atlas to Nuclear
Medicine physicians.

Nuclear Medicine physicians acknowledged the

ability of the atlas to help in training new Nuclear Medicine physicians.
The atlas was classified as an adequate teaching material for the
physicians who are developing experience to diagnose lung perfusion and
ventilation scans. In summary, the thesis demonstrates an original
contribution

to

the

nuclear

medicine

imaging

field

through

the

development of the novel anatomical lung phantom.

Keywords: Planar, SPECT, Lung perfusion, Phantom, Pulmonary
Embolism
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1. INTRODUCTION
1.1 Summary
This thesis seeks to offer the nuclear medicine imaging field a novel
anatomical lung phantom and a variety of its possible applications. In
particular, this thesis describes the development process to manufacture
and test the anatomical lung phantom to exclusively model lung perfusion
conditions of suspected pulmonary embolism (PE) patients. The thesis
introduces applications of the anatomical lung phantom as a quality
assurance device, and as a reference tool (lung perfusion imaging atlas)
using planar and SPECT imaging. The lung phantom is considered an
original and valuable knowledge contribution to the field.

The thesis is

divided into eight chapters:

Chapter 1
The chapter establishes aims and original contributions of the thesis to the
nuclear imaging field.

Chapter 2
The chapter gives an overview of literature review of the relevant and
important literature on the conducted research. The reviews are based on
journal articles, books, thesis, and conference papers.
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Chapter 3
The chapter explains in detail methods to develop the lung phantom.
Elaborate instructions on how to use the phantom in clinical studies are
included in the chapter. This chapter is an extended version of a journal
article written by the author and two co-authors. The article was entitled
‘Design and fabrication of pulmonary embolism phantom for planar and
SPECT V/Q imaging quality assurance’.

Chapter 4
The chapter describes size, Hounsfield unit values, stability, radioactivity
distribution

properties,

anatomical

properties,

and

reproducibility

characteristics of the anatomical lung phantom. In this chapter, two surveys
in close ended format were used as research instruments.

Chapter 5
The chapter contains reports on a small scale QA study on Nuclear Medicine
physicians’ interpretations accuracy in diagnosing lung perfusion images
using the PIOPED criteria. Two journal articles were written based on the
findings of this chapter. The articles have been submitted to peer reviewed
scientific journals (The Journal of Medical Imaging and Radiation Oncology,
and Canadian Association of Radiologist Journal)

for consideration for

publication. The two articles are currently under peer review.
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Chapter 6
The chapter shows the application of the anatomical lung phantom as a
reference and as a teaching tool. A lung perfusion imaging atlas was
constructed. A survey study was conducted to study the significance of the
atlas to Nuclear Medicine physicians. The chapter was written in a form
suitable for publication in scientific journals. The manuscript has been
submitted

and

currently

under

review

by

Nuclear

Medicine

Communications Journal.

Chapter 7
The chapter explains the effect of uniform water bath as an alternative
attenuation material to the lung phantom. The phantom was immersed in a
water bath prior planar scans. The scanned images were compared to the
images modelled using the lung phantom without water bath.

Chapter 8
The chapter summarises the current works and future works of the author.
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1.2 Aims
The primary aim of the thesis is to describe methods to design and develop
a novel anatomical lung phantom to simulate lung perfusion conditions of
suspected pulmonary embolism patients via planar and SPECT imaging.
The specific aims of the thesis are:
1. to summarise the main findings and reviews of subjects related to
the research,
2. to describe, in detail, the materials and the methods needed to
develop the anatomical lung phantom,
3. to give an explanation on instructions for using the lung phantom to
model lung perfusion conditions of suspected pulmonary embolism
patients with planar and SPECT imaging,
4. to compare the size of the lung phantom to the size of the human
lung,
5. to characterise the Hounsfield units of the phantom materials,
6. to describe the radiation distribution properties, anatomical
properties and reproducibility properties of the lung phantom,
7. to report a small scale QA study using the lung phantom as the main
tool,
8. to construct a novel lung perfusion planar and SPECT lung
perfusion imaging atlas,
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9. to study the water bath attenuation effects on the lung phantom
planar acquisitions.

1.3 Original contributions
The original knowledge contributions of this thesis are:
1. A novel anatomical lung phantom exclusively designed to model the
lung

perfusion conditions of suspected pulmonary

embolism

patients.
2. A reference resource and a teaching tool consisting of a lung
perfusion imaging atlas. The atlas is an informative teaching
resource and reference tool for inexperienced Nuclear Medicine
physicians that are developing experience in diagnosing lung
perfusion and ventilation scans.
3. Original methods to perform a QA study of the interpretation
accuracy in diagnosing lung perfusion images modelled using the
anatomical lung phantom.

1.4 Publications
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Kabir, N. A., Harvey, S. B. & Rosenfeld, A. 2010. Design and fabrication of
pulmonary embolism phantom for planar and SPECT V/Q imaging quality
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Peer reviewed scientific meetings (abstract only)
Kabir, N. A., Harvey, S. B. & Rosenfeld, A. 2009.

A methodology for
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2. BACKGROUND
2.1 Nuclear medicine imaging phantoms in general
Phantoms are applicable for many uses in the field of nuclear medicine
imaging. Phantoms offer a practical approach to test and evaluate imaging
techniques, and to evaluate comparison in imaging systems (1). Phantoms
have also been developed as an examination tool for medical physicist
accreditation examinations (2). Device characterisation and method testing
of SPECT imaging and Positron Emission Tomography (PET) imaging can
be done using a phantom (3). More commonly, phantoms are used in
medical imaging for quality assurance, calibration, research and teaching
(4-6). A phantom can also be used to as a training tool for nuclear medicine
practitioners (7). Phantoms are also used to verify simulated data,
planning radionuclide treatments, and demonstrating the quality of
imaging instruments (8).

Most physical phantoms used for PET and SPECT imaging are based on
either of two designs: i fillable cylinders containing either radioactive or
non-radioactive inserts; or ii complex geometry that is represented by
multiple distinct slices or sheets (9). In contrast to physical phantoms,
some researchers have developed digital phantoms (10-11). Monte Carlo
simulation is one

of

computational algorithms used

radionuclide distribution in virtual phantoms (12-13).

to

simulate
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A high quality phantom should mimic as closely as possible the imaging
routine of a patient (14). A phantom that mimics a region of the human
anatomy is called an anthropomorphic phantom (15). Constructing such
phantoms is always challenging. The phantoms must be built of tissue
equivalent materials to represent true clinical conditions (16). To find
tissue

substitute

materials

is

a

great

concern

in

designing

anthropomorphic phantoms (17). The attenuation properties of the tissue
substitute materials linearly depend on the effective atomic number of the
substances (18). The anthropomorphic phantoms should consist of
homogenous material in where test subjects are embedded (19).

There are many commercial anthropomorphic phantoms that are able to
closely resemble the attenuating properties of human tissue. In these
phantoms construction is always of utmost quality with a wide range of
applications. Commercial phantoms are not applicable when a higher level
of reproducibility; higher level of anatomical accuracy; or other qualities
are required in clinical studies (20). To overcome these limitations, many
researchers have designed unique phantoms to fully fulfil their study needs
(20).

In this thesis, a reusable semi-anthropomorphic lung phantom comprising
anatomically correct structures was constructed. The term ‘semi’ is used to
indicate that the breathing dynamic of the human lung was not considered

31

while developing the phantom. Also, the semi-anthropomorphic lung
phantom did not carry the same attenuation properties as the human lung.
Throughout the thesis, the phantom is referred to as an anatomical lung
phantom.

2.2 Available physical lung phantoms
A group of researchers (21) have developed an anatomically realistic lung
phantom to compare nuclear imaging quality in Finland. Plastic plates
were used to create the lung cavities. The cavities were filled with plastic
pallets to resemble lung tissue. A wax and plastic pellet mixture were used
to model lung perfusion defects in the cavities. The lung phantom needed
to be filled with

99mTc

solution and water prior any clinical studies. The

lung tissue has -616 HU (Hounsfield Unit) value and the perfusion defect
insert has -488 HU value. The lung phantom was not reusable. Five pairs
of the lung phantom were constructed for the study (21).

A research group from Michigan extended the existing lung insert of a
thoracic phantom (RS-330, Radiology Support Devices, Long Beach CA) to
create a deformable phantom for dynamic modelling in radiation therapy.
The extension was constructed using high density foam. The foam was
infused with iodine to better mimic lung attenuation at diagnostic imaging
kV. The reconstructed lung phantom has HU value -800 to -600. Tumor
inserts were embedded into the lung phantom for clinical studies. The
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phantom was classified as simple, efficient and viable by the researchers
(22).

A Lung-Spine SPECT phantom is a commercially available phantom
supplied by BIODEX (Shirley, New York). The left lung insert volume is
approximately 0.9 litre; and 1.1 litre of the right lung. Styrofoam beads and
water can be used to mimic lung tissue (with a density of approximately
0.3gm/cm3). The phantom is able to evaluate non-uniform attenuation and
scatter compensation methods.

A multipurpose novel anthropomorphic plastinated lung phantom has also
been designed using a pig’s lung. The lung was extracted from a pig’s
thorax; inflated; and fixed using formalin and silicone rubber. The lung
was then left to dehydrate in cold acetone. Finally, the phantom was leave
to soak in a curable silicone polymer (together with a curing agent). The
phantom retains major anatomical and imaging characteristics of an invivo lung. The phantom was used in an imaging system comparison study,
lung tomosynthesis study and many other studies (23).

The IQ and SNM’s Practitioner Acquisition Assessment Program (PAAP)
designed a 3-D lung perfusion phantom. This phantom can be used to
detect the location, extent, and significance of simulated perfusion
abnormalities. The phantom is suggested to be an appropriate tool to
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assess the ability of nuclear medicine staff, and nuclear medicine
equipment (24).

2.3 Pulmonary embolism
Venous thromboembolic disease was first discovered by an Ayurveda
physician and surgeon, Susruta, (circa 600-1000 BCE). In his medical
manuscript, he describes a patient who had a swollen and painful leg
which was difficult to treat (25-26). A French pathologist, Jean Cruveilheir,
in his book proposed the reasons for venous inflammation and thrombosis
in all disease conditions. Rudolph Virchow further investigated Cruveilheir
proposal and developed the relationship between venous thrombosis with
obstruction of the pulmonary arteries (pulmonary embolism) (25).

A blood clot (thrombus) is formed of platelets and fibrin. A thrombosis
occurs when too many (or too large) thrombi forms rapidly (27). Small
thrombi regularly clear themselves from the circulation (28). Thromboses
in the legs or pelvic veins (deep vein thrombosis); or in the lung vessels
(pulmonary embolus) carry a high risk factor (27-28).

A deep vein

thrombosis is rarely fatal but can lead to long term morbidity (27).

A pulmonary embolus usually originates from a deep vein thrombosis (28).
Larger or multiple thrombi (from deep vein thrombosis) may travel to the
heart, then on to the pulmonary arteries (28-29). Pulmonary embolism
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occurs when a thrombus partially or completely blocks a pulmonary artery
(30). The affected region of the lung will be ventilated but not perfused.
This may cause abnormalities of blood gases, pulmonary infraction and,
when extensive, can be fatal (31-32).

PE is the third most commonly occurring acute cardiovascular disease after
cardiac ischemic syndrome and stroke (33). PE will be fatal in up to 25% of
patients that have been through diagnosis but are left untreated (34). It is
a life threatening disease (35). The rate of PE is higher in women (60
cases/100 000 women) than in men (42 cases/100 000 men) (36-37).

Australian Institute of Health and Welfare (AIHW) estimated that there
were approximately 14716 cases of venous thromboembolism in Australia
in 2008 (38). The AIHW report stated that venous thromboembolism is a
bigger killer than bowel or breast cancer (38). Of the cases, 8253 cases were
estimated PE and 6462 cases were estimated DVT (deep vein thrombosis)
(38). The figure shows that PE is one of major health concerns in Australia.

Until 1998, in the United States of America (USA) approximately 200 000
deaths were recorded from PE, with 11% of patients dying in the first hour
and 38% within two hours (39). In 2006, 247 000 adults were hospitalised
in the USA with acute pulmonary embolism (36). These figures displayed a
general overview of PE in a country other than Australia.
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The work undertaken in this thesis concerns the quality assurance of PE
diagnosis via lung perfusion and ventilation (V/Q) scans. Also included in
the thesis is a lung perfusion imaging atlas to help new Nuclear Medicine
physicians diagnose PE via lung perfusion and ventilation scans. The
results of this thesis are expected to make an original knowledge
contribution to the pulmonary embolism research field.

2.4 Diagnostic algorithm for pulmonary embolism
PE diagnosis varies from one nuclear medicine department to another. The
following are diagnosis algorithms for PE in several departments.

Figure 2.1 shows diagnostic algorithm at the Department of Pulmonary
Medicine and Internal Medicine, Institute of Medical Education and
Research Sector, India (40). In the algorithm, lung perfusion and
ventilation is opted when Computed Tomography Pulmonary Angiogram
(CTPA) reports a non-diagnostic PE or when CTPA is unavailable.
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Figure 2.1: Diagnosis algorithm for PE at the Department of Pulmonary
Medicine and Internal Medicine, Institute of Medical Education and
Research Sector, India, 2009 (40).
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The European Association of Nuclear Medicine (EANM) suggested
conducting lung perfusion and ventilation scans using SPECT imaging as a
first-line
line procedure to diagnose pulmonary
pulmonary embolism, compared to
Multidetector Computed Tomography (MDCT). The lung perfusion and
ventilation scan using SPECT imaging should be widely implemented
where the modality is available, according to the EANM. The algorithm for
diagnostic imaging of suspected
su
PE patients as suggested by the EANM is
shown in Figure 2..2 (41).

PE negative
Only lung
V/Q using
planar is
available

Acute PE
suspected
Lung V/Q
using
SPECT is
available

Suspicion
of PE is
negative

PE refuted

Suspicion of
PE is
positive

Further Test

Non diagnostic
PE

Further test

PE positive

Treat OE

PE negative

PE refuted

Non
diagnostic PE

MDCT or PA

PE positive

Treat PE

Figure 2.2:: Algorithm suggested by the EANM (published in 2009) for
diagnostic imaging of patients with suspected acute PE (41). V/Q = lung
perfusion and ventilation scan. PA = contrast-enhanced
contrast enhanced pulmonary
angiography.
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Figure 2.3 shows the diagnostic algorithm for PE suggested by Hogg K. et
al. (42). The lung perfusion and ventilation scan is a following procedure
after moderate or high D-dimer blood test result. The lung perfusion and
ventilation scan is to be interpreted using the Prospective Investigation of
Pulmonary Embolism Diagnosis (PIOPED) criteria (43).
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Figure 2.3: The PE diagnosis algorithm suggested by Hogg et al. (published
in 2006) (42).
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Kuriakose et al.,, suggested a diagnostic algorithm for suspected PE based
on the clinical probability of disease in patients. Lung perfusion and
ventilation scan is recommended for patients with a normal chest X-ray
X
(44).

Figure 2.4:: Diagnostic algorithm for suspected PE recommended by
Kuriakose et al. (published in 2010) (44).. HP = High Probability.
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The four examples of diagnostic algorithm of PE as described above
demonstrate the significance of lung perfusion and ventilation scans to
diagnose pulmonary embolism.

2.5 Lung perfusion and ventilation scans
Lung perfusion and ventilation scans have been a preferred medical
imaging procedure for suspected PE for the past 30 years (45). The
ventilation scan is often performed by administering a mixed radioactive
gas (46) (a mixture of oxygen and nitrogen containing small amounts of
radioactive

133Xe

or

99mTc)

by inhalation. Diethylenetriaminepentaacetic

acid (DTPA) labelled with

99mTc

(radioaerosol) is also used in lung

ventilation scans. The perfusion scan is undertaken by injecting a solution
of macro aggregated human serum albumin (MAA) labelled with a
radionuclide (usually

99mTc)

into a peripheral vein. An uptake of the tracer

will only occur in the lung units that are perfused by blood (46-47).

The planar ventilation and perfusion scans are normally obtained in a
minimum of six to maximum eight views. The views are: i anterior (A); ii
left anterior oblique (LAO); iii left posterior oblique (LPO); iv posterior (P);
v right posterior oblique (RPO); vi left lateral; vii right lateral and viii
right anterior oblique (RAO) (46). Then, the planar perfusion and
ventilation images are compared to assess mismatch or to assess match
visible defects in the images (48). The areas of lung that are ventilated but
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not perfused (termed mismatch defects) are suggestive of the presence of
pulmonary embolism. The defect conditions basically defined by lung
perfusion and ventilation scans are: normal or near normal; non diagnostic;
very low probability; low probability; intermediate probability; or high
probability for PE (49).

Palmer et al., published comprehensive standard acquisition parameters
for lung perfusion and ventilation scans. In their study a large field-ofview, dual head gamma camera was used. The activity of

99mTc

recommended for the ventilation scan is 30 MBq, and for perfusion scan is
100 MBq. The suggested SPECT acquisition protocols were: 64 x 64 matrix
zoomed at 6.8 mm pixel size; 128 projections over 360°; each projection at
10 s for ventilation studies and 5 s for perfusion studies. The patient
inhales the

99mTc-DTPA

(TechneScan DTPA: Mallinckrodt Medical BV,

Peten, Holland) while in the supine position. The patient is then
transferred to the SPECT table to complete the ventilation acquisition. At
the completion of the ventilation acquisition,

99mTc-MAA

was injected

immediately without moving the patient. The perfusion acquisition was
then performed on the patient.
images any focal

99mTc-DTPA

To process the reconstructed SPECT

depositions (hot spot) were removed. Then, a

contour was drawn individually for each lung (the left and the right lung).
The

99mTc

clearance correction was performed to produce two corrected

projection sets: one assuming constant clearance and the other allowing
variable clearance. Finally, transverse slices were reconstructed using
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Operating System/Environment Manager (OSEM) with eight subsets and
two iterations. The resulting multi transverse slice set was normalised to
contain the same number of voxels (50).

2.6 Comparison between planar imaging and SPECT imaging for
pulmonary embolism diagnosis
PE diagnosis via lung perfusion and ventilation SPECT has better
diagnostic performance than using planar imaging (51-53). SPECT has
demonstrated better sensitivity and accuracy compared to planar imaging
for the detection of small lesions in the lungs (50, 53). SPECT imaging is a
better modality to detect subsegmental lung perfusion defects (54).
Magnussen et al., reported that SPECT images make viewing of the right
lung lower lobe medial basal segment easier (55). In addition SPECT offers
the advantage of tomographic planes and 3-D viewing (56). Lung perfusion
and ventilation scans done with SPECT imaging provide better image
quality than planar scans, thereby increasing the interpretive confidence
amongst Nuclear Medicine physicians (57).

Despite the advantages of SPECT, interpreting SPECT images of lung
perfusion and ventilation scans remain challenging for many Nuclear
Medicine physicians. Many physicians are more comfortable, and more
familiar with 2-D planar images of lung perfusion and ventilation scans
(58). Most importantly, planar imaging has established interpretative
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criteria from the PIOPED investigation team (59-60), the Hull criteria (61)
and the Gestalt interpretation (62). SPECT imaging does not offer strong
evidence-based research or criteria to help Nuclear Medicine physicians
diagnose PE via SPECT images (58). There are many cases when planar
imaging is preferred as it is widely available and easy to perform (54).

In summary, both (planar and SPECT) are currently relevant and
significant imaging modalities to acquire lung perfusion and ventilation
images. Planar imaging is a currently relevant method to acquire lung
perfusion and ventilation images. SPECT imaging is viewed as the
preferred method to acquire lung perfusion and ventilation images in the
future. More literature reviews and research on lung perfusion and
ventilation scans undertaken with SPECT imaging will establish a
comprehensive guide to help Nuclear Medicine physicians diagnose
pulmonary embolism.

2.7 Interaction of photons with matters
The nuclear composition of an isotope of an element may have a different
number of neutrons (N) to the element, but the same number of protons
(atomic number = Z) as the element (63). Some isotopes are not stable.
These isotopes will disintegrate spontaneously to reach a stable state by
emitting radiation (63-64). Three kinds of the emitted radiation are alpha
particles (α), beta particles (β), and gamma radiation (γ) (65).
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Gamma emission is dissimilar to alpha and beta emissions. Gamma
radiation is emitted by a nucleus with stable neutron to proton ratio but
having a greater nuclear energy that its resting level (excited state).
Gamma radiation is a photon (quanta of energy) emitted by an excited
nucleus.

Gamma radiation is an uncharged and short wave length

electromagnetic radiation with typical energies from 0.1 to 3 MeV (in
radioactive decay) (63).

Gamma radiation interacts with atoms as it passes through matter. Its
photon intensity is attenuated through the interaction (65). Types of
photon interactions in matter (within nuclear medicine practice) are
photoelectric absorption, Compton scattering and pair production (66). The
interactions are a function of the energy of the photons and the atomic
number, Z, of the matter (63).

Compton scattering is an interaction of photon energy with orbital
electrons that are usually at outer shells or free electrons, producing
scattered photons and recoil Compton electrons.

The scattered photons

emerge at angle, θ, relative to the initial photons’ trajectory. The energy of
scattered photons is smaller than the initial photons. The recoil Compton
electron is ejected from the atom with a particular kinetic energy (67).
Compton scattering is the dominant interaction of photons in materials
with low atomic number such as human tissue (weighted average Z=7.5).
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This interaction is the most common type of interaction of photons in the
energy range from 100 keV to 10 Mev (63).

The interaction of photons with K or L shell electrons is called the
photoelectric effect. In this interaction, energy of the photons is absorbed
completely and the orbital electron is ejected. This interaction is dominant
in photons with energy of approximately 100 keV or less (65). The ejected
orbital electron is referred as a photoelectron (67). The photoelectric effect
is a dominant interaction in material with higher atomic number such as
lead, Z= 82, (63) at lower energies. The photoelectric effect decreases
rapidly with increasing photon energy. The interaction is proportional to
the atomic number (  ) of the attenuator material (68).

Pair production interaction occurs only with high photon energies (greater
than 1020 keV). When a photon with energy in excess of 1020 keV passes
through an attenuator it transforms into two anti particles (negatron and
positron). The positron soon losses its energy and annihilates, to combine
with negatron. This annihilation produces two photons moving in opposite
direction each with energy 0.511 MeV (65, 68).

As gamma radiation passes through matter, the photon spectra can be
modified and the intensity of gamma radiation is attenuated (through the
interactions described above). The attenuation of the photons largely
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depends on: the thickness of the attenuator material; atomic number of the
attenuator material; and the initial photon energy (65).

2.8 Nuclear medicine imaging
Diagnostic imaging was invented about 110 years ago, after the first x-ray
image was recorded by Wilhelm C. Roentgen (69). The goal of diagnostic
imaging is a better understanding of the anatomy, physiology; and
pathology of the human body in improving medical prevention, diagnosis
and therapy (70). The overview of diagnostic imaging is best described by
Figure 2.5.

Figure 2.5: This schematic diagram illustrates steps in a normal diagnostic
imaging process. The first three steps are performed by the imaging
modality. The last three steps are part of visual psychophysical process
(quantitative in nature) and are performed by a radiologist (69).

The purpose of an imaging device is to produce 2-D or 3-D images of an
object. The objective of diagnostic imaging is to detect a lesion. The image
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production using imaging devices are affected by contrast, resolution, noise
and sensitivity (69).

The fundamental concept of nuclear medicine imaging is based on the
external

detection

of

biodistributed

radiotracers

that

have

been

administered to patients. Physiological uptake, distribution, and excretion
allow clear understanding of the presence or absence of disease in the
patient.

Nuclear

medicine

reflects

the

biodistribution

of

radiopharmaceuticals and therefore the physiology, anatomy, pathology,
and artefact overlays of a patient present at the time of imaging. Usually a
radioisotope is combined with a physiological compound to create a
radiopharmaceutical.

Radiopharmaceuticals

can

be

administered

to

patients via intravenous; oral; or injection (71).

Gamma camera
Gamma cameras are stationary imaging devices that are commonly used in
nuclear medicine. These cameras are able to detect radiation across the
entire field of view. Gamma cameras are capable of recording dynamic as
well as static images of the area of interest in the patient.

The basic design of most gamma camera is based on the Anger camera (72)
The basic components of a gamma camera are: i collimator; ii NaI(Tl)
detector; iii photomultiplier tubes; iv preamplifier; v amplifier; vi X, Y
positioning circuit; vii summing circuit; viii pulse height analyser; ix and

49

viii computer unit (72). Figure 2.6 illustrates a basic gamma camera
configuration.

Figure 2.6: The picture illustrates components of nuclear medicine imaging
system (63, 70).

There are many types of collimator for different photon energies and for
many imaging qualities (63). The collimator is attached to the NaI(Tl)
detector to limit the field of view so that gamma (γ) radiations from outside
the field of view are prevented from reaching the detector (72). Photons
emitted from other directions will be absorbed by the collimator septa (63).
Parallel collimators are the most commonly used type in nuclear medicine
procedures (72).
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The NaI(Tl) detector is a clear crystal in which gamma radiation interacts,
thereby converting the radiation to light photons. Photomultiplier tubes
generate a pulse in response to the light photons. Each γ radiation
interaction generates a pulse projected at the X, Y coordinate point of
interaction of the γ radiation (72). A preamplifier amplifies the pulse to
allow it to be transmitted through a cable to the main amplifier for further
amplification (63). X, Y positioning circuits correlate the X, Y coordinate on
the image to the X, Y coordinate at the point of interaction of the γ
radiation. A summing circuit provides summed pulses, and creates Z
(energy) pulses (72). A pulse height analyser analyses the amplitude of Z
pulse. The computer of a gamma camera imaging system is used for
acquisition, storage and data processing (63, 70).

Single photon emission computed tomography (SPECT)
A typical SPECT system consists of gamma detectors (one; two; or three)
mounted on a rotating gantry (72). A computer for acquisition and
processing data; and a display system are normally included in the system.
The detectors rotate at a small angular increments (3° – 10°) until a full
360° rotation is completed. Data collected at each rotation are recorded for
later reconstruction (72). Images in the transverse, sagittal, and coronal
planes are generated from the collected data using image reconstruction
software (72). SPECT imaging allows the localisation of radiation signals
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from complex organ structures for critical patient diagnosis and
management (73).

2.9 ImageJ software
ImageJ is an open source software developed by the National Institute of
Health (NIH), Bethesda, Maryland. The software is able to display, edit,
analyse, process, save and print 8-bit, 16-bit, 32-bit images. The analysis
tools allow area and pixel calculation of an image. The software is also able
to measure distance and angles of pixels. Statistical programs are included
in the software package. It also supports standard image processing
functions such as contrast manipulation, sharpening, smoothing, edge
detection and median filtering. The software is usually used in microscopy,
gel, astronomy and medical imaging fields (74). The software package was
used for image analysis in this thesis.
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3. DESIGN AND DEVELOPMENT OF AN
ANATOMICAL LUNG PHANTOM

3.1 Introduction
This chapter consists mainly of previously published article by the author
and two co-authors in the Australasian Physical & Engineering Sciences in
Medicine Journal (48). Also, the chapter contains material previously
presented as posters at the 39th and the 40th Annual Scientific Meeting of
the Australian and New Zealand Society of Nuclear Medicine. Abstracts of
the posters have been published in the Internal Medicine Journal (75-76).

3.2 Concept
The fundamental phantom design focuses on its ability to model
anatomical lung perfusion defects of patients suspected having pulmonary
embolism. The basis for the phantom’s development was to assess quality
assurance in diagnostic imaging. The phantom was also built as a teaching
tool and reference resource for Nuclear Medicine physicians.

Steps taken to manufacture the phantom were carefully planned to ensure
its ability to achieve the research objectives. The essential characteristics
of the phantom are: i reusable; ii water tight; iii stable; and iv easy to
handle. One other key features of the phantom is its approximate
anatomical resemblance to the human lungs. These characteristics
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facilitate the application of the phantom to the generation of lung perfusion
images as depicted in lung perfusion and ventilation scans.

3.3 Limitations
The phantom does have some limitations. For instance it does not share
the exact tissue textures and mechanical properties of human lungs. Also,
the distribution of radioactivity in the phantom does not exactly resemble
the distribution of pulmonary blood flow.

These characteristics were

omitted in order to minimise cost and lessen the development time.

Normally, to diagnose the probability of pulmonary embolism, both lung
ventilation and perfusion images are compared. The areas of lung that are
ventilated but not perfused are suspected of having pulmonary emboli
(termed mismatch defects) (48, 77). In this thesis however, lung ventilation
scans will not be simulated or modelled. Lung ventilation is assumed to be
perfect in this research. Therefore, all lung perfusion deficiencies modelled
using the lung phantom will be considered as V/Q mismatch defects.

3.4 Lung anatomy
The lung phantom was constructed to duplicate the anatomical structures
of human lungs as closely as possible. To ensure anatomical similarity, the
anatomy of human a lung was studied prior to manufacturing the
phantom.
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The lungs are comprised of two tree-like structures: the vascular tree and
the airway tree. Arteries, veins and capillaries comprise the vascular tree.
The airway tree consists of series of hollow branching “pipelines” that
decrease in diameter at each division. The airway tree begins at the
trachea, which divides into two bronchi, the right bronchus and the left
bronchus. Each bronchus enters a lung and then splits and sub-splits
numerous times forming bronchioles. Terminal bronchioles are the
smallest airways in the tree. The terminal bronchioles lead the airway path
into the respiratory zone. This zone consists of alveolar ducts and alveolar
sacs that eventually terminate at the alveoli. There are millions of
clustered alveoli occupying spaces in the lungs. Thus, the lungs are
actually air spaces interspersed with lung tissue (78).

As the trachea divides, the bronchi diverge at greater angles to reach the
left and right lung tissues. The right lung has three lobes; upper lobe,
middle lobe and lower lobe. Each lobe is supplied by an individual lobar
bronchus. The right lobar bronchi are further divided into ten segmental
bronchi. The left lung has two lobes: upper lobe and lower lobe. Each lobe
has its own bronchus (lobar bronchus). The left lobar bronchi are further
divided into ten segmental bronchi. Each segmental bronchus of the left
lung and the right lung is occupied with clustered alveoli; forming a
functional bronchopulmonary segment Figure 3.1 (79).
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Figure 3.1. a The right lung (lateral view). b The right lung (medial view). c
The left lung (lateral view). d The left lung (medial view). e Segmental
bronchi. Each segmental bronchus was numbered corresponding to its
matching bronchopulmonary segment (29).

An anatomical human lung model (Figure 3.2) (American 3B Scientific,
Atlanta,

USA)

was

used

as

a

reference

model

throughout

the

manufacturing process. The model was cast from an actual human lung
with representation of bronchial tree, bronchioles and alveoli. It has 18
segments held together elastically which allows easy viewing of the lung
structures; ten bronchopulmonary segments of the right lung and eight
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bronchopulmonary segments of the left lung. Commonly, the apical and the
posterior segments of the left upper lung lobe are regarded as a single
segment (referred as apicoposterior segment). Also, the medial basal and
the anterior basal segments left lower lung lobe are frequently fused and
considered as a single segment (80). These combinations result in eight
instead of ten bronchopulmonary segments of the left lung.

Figure 3.2: The reference lung model (American 3B Scientific, Atlanta,
USA). The model is made of 18 colour coded bronchopulmonary segments,
with all segments attached elastically.

3.5 The anatomical lung phantom components
The anatomical lung phantom consists of two hollow anatomical lung
cavities, perfusion defect inserts and lung tissue. The following describes
the process to manufacture all the phantom’s components.

The right lung cavity and the left lung cavity
Polymorph (Nucletron Pty. Ltd, Newtown, Australia) plastic sheets were
used to manufacture the two lung cavities. These plastic sheets are a
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specially formulated rigid low melting temperature thermoplastic for bolus
applications in radiation oncology. This material is available in a pre-cut
sheet, 60 cm long and 45 cm wide, with a thickness of 2mm.

Two plastic sheets were used to manufacture the lung cavities, one for each
cavity. Each sheet was cut into three pieces. The plastic sheets were placed
in a water bath at a temperature of 65°C. A nylon mesh was placed into the
water bath to prevent the material from sticking to the metal parts of the
bath. The polymorph plastic material softens and becomes transparent on
heating. One of the polymorph plastic pieces was moulded against the
reference lung model (the left lung), creating the first part of the cavity.
This was then removed from the model. These steps were repeated for the
other two pieces of the polymorph plastic sheets, creating the second and
third parts of the left lung cavity. The edges of the first and second parts
were attached to each other, creating the left lung cavity. The third part of
the cavity became the lid of the left lung cavity. All of the above steps were
repeated in order to create the right lung cavity. A valve was installed on
each lung cavity in such a way as to facilitate the filling and draining of
water and

99mTc

solution. Overall, dimensions of the cavities varied by ± 2

mm compared to the reference lung model.
Figure 3.3 and Figure 3.4 show the right and the left lung cavities,
photographed next to the reference lung model. The figures show that the
cavities were manufactured with a shape of the reference lung model.
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Figure 3.3: a The left lung cavity. b The left lung cavity and the left lung
reference model. c The right lung cavity. d The right lung cavity and the
right lung reference model.

Figure 3.4:

a The left lung cavity filled with EPS beads, with a valve

shown in green colour. b The lid for the left lung cavity. c The right lung
cavity filled with EPS beads, with a valve is shown in green colour. d The
lid for the right lung cavity.
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Perfusion defect inserts
The reference lung model (Figure 3.2) was also used as an anatomical
reference to manufacture the perfusion defect inserts. The perfusion defect
inserts manufacturing process began by creating negative moulds for the
perfusion defect inserts. A chromatic dental alginate (Adelaide Moulding &
Casting Supplies, Adelaide, Australia) was used to create the moulds.
Equal amounts of water and alginate powder (1 : 1 ratio) were mixed in a
container, forming an alginate solution. A single bronchopulmonary
segment of the reference lung model was immersed into the alginate
solution. The alginate solution firmed up after 1-2 minutes. The
bronchopulmonary segment was then gently removed from the alginate,
producing a negative mould.

Polyester resin (Solid Solutions, East Bentleigh, Australia) with a few
drops of Methyl Ethyl Ketone Peroxide (MEKP) catalyst (Solid Solutions,
East Bentleigh, Australia) were used to manufacture the positive structure
(perfusion defect inserts) of the negative moulds. Approximately 29 drops
of MEKP catalyst was needed for every 100 ml of polyester resin. The
polyester resin and MEKP catalyst mixture was poured into the alginate
negative moulds and left for up to five days to cure. The cured polyester
surface was sticky, and a post-curing process (air exposure at room
temperature) was carried out in order to fully cure the polyester. The fully
cured polyester took on the impression of the bronchopulmonary segment
of the reference lung model. Several of the manufactured perfusion defect
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inserts are shown in Figure 3.5. Each perfusion defect insert in Figure 3.5
were photographed next to its reference bronchopulmonary segment, in
order to show the anatomical similarity shared between the two objects.

Figure 3.5: a The anatomical bronchopulmonary segments of the reference
lung model. b The perfusion defect inserts for the lung phantom.

The polyester casting process was repeated to produce ten anatomical
perfusion defect inserts for the right lung cavity and eight anatomical
perfusion defect inserts for the left lung cavity. For the right lung cavity,
the manufactured perfusion defect inserts were termed apical, posterior,
anterior, medial, lateral, superior, medial basal, anterior basal, lateral
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basal and posterior basal segments. For the left lung cavity, the defects
were termed apical-posterior (commonly referred to as a single segment),
anterior, lingular superior, lingular inferior, superior, medial basalanterior basal (commonly referred to as a single segment), lateral basal
and posterior basal segments.

Silicon sealant was used to separate and attach the perfusion defect inserts
together; corresponding to any the clinical lung perfusion defect
requirements (single segmental perfusion defect or multi-segmental
perfusion defects). Figure 3.6 shows the perfusion defect inserts for the
right lung cavity. In Figure 3.6, silicone sealant was used to attach the
perfusion defect inserts to make the right upper lobe; the right middle lobe;
and the right lower lobe. Figure 3.7 shows the perfusion defect inserts for
the left lung cavity.

Figure 3.6: a All the perfusion defect inserts for the right lung attached
together. b The perfusion defect inserts for the right upper lobe: comprising
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apical, posterior and anterior segments. c The perfusion defect inserts for
the right middle lobe: comprising medial and lateral segments attached
together d The perfusion defect inserts for the right lower lobe: comprising
superior, medial basal, anterior basal, lateral basal and posterior basal
segments.

Figure 3.7: The perfusion defect inserts for the left lung.

a Apical and

posterior segments (commonly referred to as a single segment). b Anterior
segment. c Lingular superior segment d Lingular inferior segment. e
Superior segment. f Medial basal and anterior basal segments (usually
considered as a single segment). g Lateral basal segment. h Posterior basal
segment.
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Lung tissue
Expanded polystyrene beads, EPS, (C8H8)n were used to simulate lung
tissue (with efficient lung perfusion) in the lung cavities (see Figure 3.4).
Polyester (C10H8O4)n resin was used to manufacture the lung perfusion
defect inserts. These inserts were employed to simulate areas of deficient
lung perfusion. Attenuation responses of the 140keV of 99mTc solution differ
within the lung tissue simulated by EPS beads and within the lung area
simulated by perfusion defect inserts.

The effective atomic number, Zeff, of a compound can be calculated using
Equation 1 (81).

(   +  



+    + … … … ) Equation 1

where:
ai: Fractional content of element of the ith element.
Zi: Atomic number of the ith element.

The Zeff of EPS beads is 5.7 while for the polyester resin it is 6.6, as
calculated using

Equation 1. Mass attenuation coefficient is highly

dependent on the atomic number of the absorbing material (63) Mass
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attenuation is fraction of photon absorbed or scattered from monoenergetic
beam. The mass attenuation coefficient is independent of density
(82).Consequently, the mass attenuation coefficient, µ/ρ, is higher for the
perfusion defect inserts, as it has higher Zeff, compared to the EPS beads.
Furthermore, the perfusion defect inserts are relatively thicker than the
EPS beads. Thus, the resulting attenuation in the solid defects is higher
than in the EPS, resulting in non-uniform attenuation in the lung cavities.

The density of the perfusion defects of the lung phantom does not resemble
the density of lung tissue. This is because the realistic density property of
the phantom has been compromised to accommodate better anatomical
features of the phantom. The polyester resin was chosen to manufacture
the perfusion defect inserts because the material was able to better hold
lung shapes and features. In this thesis, the lung phantom was
manufactured with the aim of resembling the human lung as close as
possible. Anatomical resemblance to a human lung is important for later
studies (Chapter 5 and Chapter 6).

3.6 Assembly of the lung phantom
The anatomical lung phantom is reusable. The following are the steps
required to model a lung perfusion defect as depicted in lung perfusion and
ventilation scans.
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To use the phantom, one or more perfusion defect inserts are placed into
the lung cavities in the correct anatomical positions. Silicon sealant is used
to seal the bronchopulmonary segments into the lung cavities. The lung
cavities are then filled with EPS beads. Next, the lung lids are attached to
the cavities, and the lids sealed to the cavities using silicone sealant.
Finally, through the lung cavities’ valves, the lung cavities are filled with
water and an appropriate activity of

99mTc

solution. Figure 3.8 shows the

step-to-step procedure to prepare the phantom with a perfusion defect in
the left lung lower lobe posterior basal segment.

Figure 3.8: The steps taken to prepare the phantom for a perfusion scan. a
The left lung lower lobe posterior basal defect insert was fitted into the left
cavity at its anatomical position. The green cap on the picture is the filling
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and draining valve for the cavity b Magnified view of the image a. c The
cavity is filled with EPS beads. d Silicone sealant is piped around the
cavity. e The lid is attached to the cavity. Coloured water is then poured into
the cavity ei The perfusion defect area is free of coloured water (dotted
circle). f Appropriate activity of

99mTc

solution is added to the assembled

phantom, leaving the phantom ready for a planar or SPECT scan.

3.7 Imaging protocols
In this thesis, all planar and SPECT scans were acquired with the same
imaging protocols as at the Department of Nuclear Medicine, Wollongong
Hospital, NSW, Australia.

A dual head gamma camera ‘Philips ADAC

Forte’ with a Low Energy High-Resolution (LEHR) collimator was used for
all acquisitions. Figure 3.9 shows the phantom being scanned using the
dual head gamma camera. To begin the planar or the SPECT perfusion
scans, an appropriate activity (approximately 40-50 MBq) of 99mTc solution,
was added into the assembled phantom (Figure 3.8). The usual dosage of
99mTc-MAA

for lung perfusion imaging recommended by the Society of

Nuclear Medicine (SNM) is 40-150 MBq (83).

Conventionally, lung perfusion images are compared with lung ventilation
images to observe perfusion-ventilation mismatch or match patterns within
bronchopulmonary segments (54). This comparative step was omitted in
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this study because the research was aimed at only studying lung perfusion
defects.

Figure 3.9: The lung phantom while on a scan procedure at Department of
Nuclear Medicine, Wollongong Hospital, NSW, Australia.

Planar acquisition
In each planar scan, six planar views were acquired in a 256 x 256 matrix:
anterior (A), posterior (P), left anterior oblique (LAO), left posterior oblique
(LPO), right posterior oblique (RPO) and right anterior oblique (RAO). The
planar perfusion scans were acquired at a 140 keV photopeak. The planar
perfusion image set was then printed on x-ray film and also stored
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electronically in the hospital PACS (Picture Archiving and Communication
System). Figure 3.10 shows an example of planar perfusion images
modelled using the phantom.

Figure 3.10: Planar perfusion images of a simulated lung perfusion event at
six different views. The arrow shows the perfusion defect within the left lung
lower lobe posterior basal segment.

At the Nuclear Medicine Department, Wollongong Hospital, planar lung
perfusion acquisition time (on a dual head camera) is about 10 to 15
minutes. In this research, planar lung phantom perfusion acquisition time

69

is approximately 12 minutes (when administrated

99mTc

activity into the

lung phantom cavities is approximately 40-50 MBq).

SPECT acquisition
In each SPECT scan, a step-and-shoot protocol of 12 s/3°step for a total of
60 views per camera head was used. Images were collected at the 140keV
energy window immediately after the planar acquisition. The lung SPECT
image set was reconstructed using a HERMES workstation (Hermes
Medical Solutions, Stockholm, Sweden). Reconstruction of coronal, sagittal
and transverse slices were done using filtered back-projection (FBP) with a
Butterworth cut off value of 0.4. The raw and reconstructed images were
stored in digital format on the hospital PACS. Reconstructed SPECT
images were viewed on the HERMES workstation and also printed on xray film. Figure 3.11 shows an example of SPECT perfusion images
modelled using the phantom.
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Figure 3.11: SPECT perfusion tomographic slices of the right upper lobe
defect. a Selected coronal slices from anterior to posterior show a clear
defect in the right upper lobe. b Selected sagittal slices from right to left
show sharp edges of the right upper lobe defect. c Selected transverse slices
from head to feet show the defect in the right upper lobe.
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4. CHARACTERISTICS OF THE
ANATOMICAL LUNG PHANTOM

4.1 The lung phantom size
The anatomical lung phantom (48) design was based on a reference
anatomical human lung model (American 3B Scientific, Atlanta, USA). The
reference model was cast from an actual human lung. The reference lung
model was used to ensure that the phantom mimicked the physical
dimensions of the human lung.

The anatomical lung phantom was manufactured to closely represent the
shapes and the size of the human lung. The lung phantom dimensions are:
23 cm height; 28 cm width; 13.7 cm depth (see Figure 4.1). The human
lungs vary in size and formation. Miller, in his book, reported the average
height of the right lung and the left lung in a group of males are 27.1 cm
and 29.8 cm respectively and in a group of females are 21.6 cm and 23 cm
respectively (84). Average depth measurements at the base of the right
lung were 13.5 cm in a group of males and 12.2 cm in a group of females,
and of the left lung were 12.9 cm in a group of males and 10.8 cm in a
group of males (84). The height and depth measurements of the
manufactured lung phantom are considered within acceptable ranges of
height and depth measurements of the human lung.
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Figure 4.1: The dimensions of the anatomical lung phantom. a The right
lung. b The left lung.

Height, width, depth, perimeter and length measurements of the phantom
were measured at several points as depicted in Figure 4.1 and in Figure
4.2. The measurements are shown in Table 4.1.
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Figure 4.2: a The A, B, and C points are the perimeter points measured on
the left lung. Line 1 is the height of the left lung. Line 2, line 3, and line 4
are the transverse measurements of the left lung. b The D, E, and F points
are the perimeter points measured of the right lung. The line 5 is the height
of the right lung. Line 6, line 7, and line 8 are the transverse measurements
of the right lung.
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Table 4.1: Measurements of the lung phantom at several points (see Figure
4.2). Line 1 and line 5 are height measurements of the left lung and the
right lung respectively. Line 2, line 3, and line 4 are transverse
measurements of the left lung. Line 6, line 7, and line 8 are transverse
measurements of the right lung.
Perimeter

Length

Point

Perimeter (cm)

Line

Length (cm)

A

28.5

1

23.0

B

45.5

2

13.6

C

46.8

3

13.0

D

34.0

4

8.3

E

61.0

5

20.6

F

59.5

6

11.8

7

13.7

8

4.6

The height of the left lung (line 1) and the right lung (line 5) are 23.0 cm
and 20.6 cm respectively. The transverse measurement at the base of the
left lung (line 3) and the right lung (line 7) are 13 cm and 13.7 cm
respectively. Miller in his book reported that the right lung is shorter and
broader than the left lung (84). Measurements of the anatomical lung
phantom follow the measurement pattern reported by Miller in his book
(84). These measurements were taken to confirm that the manufactured
lung phantom size is approximately as the size of the human lungs.
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4.2 Hounsfield units
Computed tomography (CT) scanners associate gray value scale value of a
material produced during CT scanning with its attenuation value in
Hounsfield units (HU). The HU range of CT scanners

is from +1000

(cortical bone) to -1000 (air); with water having a HU value of 0 (85). Dense
materials (for example muscle tissue, liver, and bone) that attenuate x-ray
more than water have positive HU values. Less dense materials (for
example lung and adipose tissue) have negative HU values, attenuate xray lesser than water (69). By definition,

  =

  


. 1000

(Equation 2)

where µm is the linear attenuation coefficient (measured in cm-1) for the
object being scanned and µw is the linear attenuation coefficient (measured
in cm-1) for water (86).

In this thesis, the HU values of the anatomical lung phantom were
identified. The lung phantom was submerged in a water-filled container,
then scanned using a CT scanner. Figure 4.3 shows the CT image and
corresponding schematic diagram of the lung phantom. The scan was
acquired at a setting of 120 kVp. HU numbers of the lung phantom
materials are listed in Table 4.2.
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Figure 4.3: a The CT scan image (axial plane) of the lung phantom with a
perfusion defect insert fitted in the left lung. b Schematic diagram of the
lung phantom in a water-filled container.

Table 4.2: HU numbers of the anatomical lung phantom. Material numbers
are listed as illustrated in Figure 4.3
Material
Material

HU Number

Number
1

Water

0

EPS beads with
2

-578
water
Perfusion defect

3

114
insert

The HU values in Table 4.2 were compared to published HU values of lung
tissues. The anatomical lung phantom (lung tissue and perfusion inserts)
has higher HU values compared to human lungs. Benseler, in his book
recorded a HU value of lung as -903.5 (85). For non-smokers the lung HU
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value range is reported as being from -720 to -880 (87). A study by Ezra et
al. reported a mean HU value of females’ lungs as -722 (SD=44) and of
males’ lungs as -746 (SD=42) (88). A study reported -648 ± 27 (mean ± SD)
HU value of subjects’ lung after strenuous, prolonged exercise (89).

CT images display gray shades of attenuated x-rays within the
corresponding voxel (90). X-ray attenuations values measured by CT
scanners are expressed in Hounsfield Units (90) (see Equation 2).
Materials that attenuate x-ray more than water have positive HU values,
while materials with less attenuation than water have negative HU values
(69). The EPS beads with water that are used to resemble lung tissue
within the efficient lung perfusion area have less attenuation than the
perfusion defect inserts (that are used to resemble lung tissue within the
deficient lung perfusion are).

As explained in Chapter 3, the realistic

density property of the phantom has been compromised to accommodate
better anatomical features of the phantom. The specific materials were
chosen to fabricate the phantom as they simplified the moulding process of
the phantom. The chosen materials effectively maintained the anatomical
shape of the human lungs. This was a key point in ensuring the phantom’s
ability to be used in our later clinical studies.
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4.3 Count rate stability of the phantom
Pulmolite (Pharmalucence, Massachusetts, USA) is a kit for the
preparation of

99mTc

MAA used at the Department of Nuclear Medicine,

Wollongong Hospital. The kit preparation instructions suggest an
intravenous dose range for the average patient (70kg) of 37 to 148 MBq of
99mTc

MAA.

The lung perfusion scan protocol at the Department of Nuclear Medicine,
Wollongong Hospital requires 600 000 counts for each planar projection. In
this thesis, a trial and error procedure was applied which determined that
the radioactivity of the

99mTc

solution should be maintained at 40-50 MBq

for each lung phantom scan. The trial started by administrating 2ml of 20
MBq

99mTc

solution into each lung cavity. The radioactivity of

99mTc

solution was adjusted to achieve 600 000 counts per planar view at an
appropriate acquisition time. The trials ended after the sixth trial with a
radioactivity of a 2 ml

99mTc

solution of 60 MBq. After discussion and

consultation with the medical physicist and technologists, the radioactivity
of

99mTc

solution was restricted to 40 - 50 MBq for each lung cavity. The

specified activities of

99mTc

were chosen for the lung phantom in order to

closely mimic a patient planar lung perfusion acquisition time at the
Wollongong Hospital (refer to Sub-chapter 3.7). One of the purposes of the
lung phantom is to be used as a teaching tool. A good quality of teaching
phantoms should be able closely mimic scan acquisitions of actual patients.
It was considered necessary for the lung phantom to closely mimic patient
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acquisition time as it purpose as a teaching aid was taken into
consideration.

A study was carried out to investigate the lung phantom’s stability in
relation to the time taken for each acquisition to reach the maximum
counts per planar view. Three lung perfusion defect cases (Case 1, Case 2
and Case 3) were selected for the study, with each case being repeated
three times, making a total of nine lung planar perfusion scans. The names
of planar perfusion scans were: Case 1 for Lung Scan 1, Lung Scan 2 and
Lung Scan 3; Case 2 for Lung Scan 4, Lung Scan 5 and Lung Scan 6; and
Case 3 for Lung Scan 7, Lung Scan 8 and Lung Scan 9. These scans made
up the three statistical populations of measurements:

1. Population 1 (consists of Lung Scan 1, 2, and 3),
2. Population 2 (consists of Lung Scan 4, 5, and 6), and
3. Population 3 (consists of Lung Scan 7, 8, and 9).

Population 1 consists of planar perfusion scans of the lung phantom with a
non-existent perfusion defect. Population 2 consists of planar perfusion
scans of the lung phantom with a perfusion defect in the left lung upper
lobe apical-posterior area. Population 3 consists of planar perfusion scans
of the lung phantom with a perfusion defect within the right lung lower
lobe lateral basal segment. The left lung and the right lung cavities were
loaded with 2 ml of

99mTc

solution (40 - 50 MBq) for each planar perfusion
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scan. The mean values and one standard deviation values of

99mTc

radioactivity of each statistical population were calculated and listed in
Table 4.3.

Table 4.3: Radioactivity of 99mTc solution in each lung cavity.
Administered 99mTc radioactivity (MBq)
Population 1
Lung Scan

LS1 1

LS 2 LS 3

The RL2
42.7
42.7 43.6
cavity
The LL3
43.1
41.0 42.9
cavity
M ± SD4 of
42.7 ± 0.9
administrated
radioactivity

Population 2

Population 3

LS 4 LS 5 LS 6

LS 7 LS 8 LS 9

41.2

43.2

44.7

42.5

49.3

43.8

44.0

39.1

42.0

40.7

48.0

39.9

42.4 ± 2.1

44± 3.9

Six planar views (A, LAO, LPO, P, RPO, and RAO) were acquired for all
scans in Population 1, Population 2, and Population 3. The time taken for
each planar projection to reach 600 000 counts was recorded. The end to
end distances from the lung phantom to the camera for all six views were
not the same. This distance affects the time required to complete each
planar projection. Also, the volume of the lung perfusion defects affects the
time taken to reach 600 000 counts per planar view.

The mean and

standard deviation of the time taken to reach the maximum counts at each

LS = Lung scan
RL = Right lung
3 LL = Left lung
4 M ± SD = Mean ± one standard deviation
1
2
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planar view (for all lung scans) are shown in the bar charts of Figure 4.4,
Figure 4.5, and Figure 4.6.

Planar view

RAO

112.13

RPO

121.66

Posterior

116.50

LPO

122.67

LAO

111.92

Anterior

106.11

0.00

20.00 40.00 60.00 80.00 100.00 120.00 140.00
Mean time (s)

Figure 4.4: Mean values and standard deviation bars of time taken to reach
maximum counts for each planar view of lung scans in Population 1.

Planar view

RAO

67.00

RPO

71.60

Posterior

70.13

LPO

74.94

LAO

66.33

Anterior

64.14

0.00

20.00 40.00 60.00 80.00 100.00 120.00 140.00
Mean Time (s)

Figure 4.5: Mean values and standard deviation bars of time taken to reach
maximum counts for each planar view of lung scans in Population 2.
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Planar View

RAO
RPO
Posterior
LPO

103.49
110.53
103.21
109.24

LAO

99.23

Anterior

96.05

0.00 20.00 40.00 60.00 80.00 100.00120.00140.00
Mean time (s)

Figure 4.6: Mean values and standard deviation bars of time taken to reach
maximum counts for each planar view of lung scans in Population 3.

The bar chart in Figure 4.6 illustrates higher standard deviations of times
taken to reach the maximum counts for all planar views in Population 3,
when compared to Population 2 and Population 1. The possible
explanations behind the situations are the end to end distance of the lung
phantom to the camera at each acquisition in population 3 differs greatly
from one to another. Radioactive decay was not considered as a factor
because the

99mTc

solutions in the phantom decayed with the same half-life

(6.6 hour) in all scans. The end to end distance of the lung phantom to the
camera was observed of all acquisitions in later clinical studies. The action
was taken to ensure similar times will be taken to reach maximum counts
for two or more scans acquired with the same acquisition parameters.
Also, the action contribute towards improving reproducibility quality of the
phantom
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4.4 Radioactivity distribution
Planar and SPECT imaging allows the visualisation of the distribution of
radioactivity within the human body (91). The imaging reveals the
structure, and physiology of organs’ functions. Most nuclear medicine
departments have imposed quality assurance and quality control
procedures to ensure high quality imaging. One of most applied methods to
perform quality assurance and quality control in diagnostic nuclear
medicine is by using phantoms. It is recommended that the phantoms are
filled with the same radiopharmaceutical as applied to a patient (92). The
radioactive solution (99mTc) has to be equally and homogeneously
distributed throughout the lung phantom cavities.

To study the lung phantom’s homogeneity, three conditions of planar
perfusions were modelled. Each planar perfusion condition scan was
repeated three times, making at total of nine lung scans for the study. All
the acquired planar scans are in fact the same planar perfusion images
Section 4.3.

The homogeneity properties of the phantom were studied using the ImageJ
software (National Institutes of Health, USA). Pixel intensities of any
planar images acquired using the phantom were assumed to have a linear
relationship with the radioactivity concentration of

99mTc

solution.

The

intensity of each pixel recorded using ImageJ is a reconstructed intensity of
its corresponding voxel.
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The first step to study the homogeneity of the radioisotope distribution was
convert the planar image an 8-bit image with 0 - 255 grayscale shades
(black = 0 and white = 255). Next, a selection tool was used to draw
selection maps (yellow circles) on the lung images (Figure 4.7). There are
two selection maps drawn on each planar image; making a total of 18
selection maps all together. Each map was carefully drawn, where all
voxels within the map are at similar length (similar thickness). This step
was taken into consideration as the thickness of the lung phantom varies.

Figure 4.7: Selection maps drawn on the lung images (anterior view) using
the selection tool of the ImageJ software
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The regions of interest within the selection maps were then analysed using
the ‘analyse’ tool of the software. The analysis reported a mean and
standard deviation of the pixels’ intensities within each selection map.
Then the distribution of pixel intensities in each selection map was plotted
using the software. Finally the skewness of the distribution plots of all
selection maps were calculated using the software.

Skewness is the third order moment about the mean (74). For a sample size
of n, the skewness would be:
#

Skewness = (#)(#

)

∑'
&()(%&  %*+, )
-

(Equation 3)

where:
n : sample size
s : sample standard deviation
./01 : mean value
.2 : each value in the sample

These distribution plots are shown in Figure 4.8. The number of pixels in
each selection map, the mean, standard deviation and skewness of the
pixels’ intensities of each selection map are listed in Table 4.4.
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Figure 4.8: Distribution plots of pixels’ intensities on a 0-255 greyscale of 18
Selection Maps5. The plots were generated using the ImageJ software.

Distribution plots of the 18 selection maps in Figure 4.8 are moderately
skewed but each distribution has a unimodal mode. Unimodal is one of the
normal distribution properties (93). Most of the selection map distributions
5

SM = Selection maps
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have skewness values close to zero. A skewness statistic in the range of ±1
is usually acceptable to conclude that the distribution fits a normal
distribution pattern (94-95). Therefore, all 18 selection maps are normally
distributed.

Table 4.4: The table lists number of pixels, mean intensity of the pixels and
its standard deviation, and skewness of the selection maps.
Selection
map
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

Number of
pixels
2072
2724
1672
2376
2638
1565
1490
1310
1724
1928
1650
1803
2482
1690
1490
1576
1444
1310

Mean
intensity
41.58
37.04
61.40
41.67
49.88
42.71
55.96
40.42
71.41
41.22
56.61
42.72
60.02
53.61
50.24
45.97
45.17
48.96

SD

Skewness

2.66
2.85
6.46
1.99
4.24
2.09
4.84
1.74
8.45
1.77
3.15
1.34
6.28
3.90
3.25
1.64
1.78
2.34

0.28
0.34
0.31
0.25
0.58
0.36
0.34
0.29
0.46
0.23
0.41
0.00
0.35
0.83
0.60
0.10
0.32
0.21

The mean is usually the best measure of the central tendency of normally
distributed data (96). In a normal distribution, 68% of the data will lie
within ± 1 standard deviations (SD) of the mean.
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The intensity of each pixel represents the radioactivity concentration at
where the pixel is located on planar image. Standard deviation of pixels
values are small (Table 4.4) for most parts of the phantom during three
independent charging with

99mTc.

Therefore, the

99mTc

concentration was

quite uniformly distributed within one piece in the lung phantom for a
particular part charged with

99mTc.

Uniform distribution of the

99mTc

is

expected only within a particular part (within a selection map) of the
phantom. Uniform distribution of

99mTc

are not expected the same pixel

value (apparent activity) for different parts (different selection maps) of the
phantom, as they are different in shape and can have different uptake of
99mTc.

4.5 Anatomical properties
Quality control and quality assurance measurement programs used in
clinical practice are optimal when they mimic the complete medical
imaging process including interpretation of the images by a radiologist (16,
98).

Anthropomorphic phantoms are able to provide physical representations
and attenuation properties of human anatomy in nuclear medicine studies.
These phantoms are designed to radiologically mimic body components
(shape) and materials composition (structure) (99-100). In this thesis, a
reusable semi-anthropomorphic lung phantom comprising anatomically
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correct lung structure was developed. The term ‘semi’ was used because the
breathing (ventilation) dynamics of the human lung was not considered
while developing the phantom.

Three lung perfusion defect conditions (Clinical condition 1; Clinical
condition2; and Clinical condition 3) were simulated using the anatomical
lung phantom. The first clinical condition was lung perfusion without
deficiency; the second clinical condition was lung perfusion with the left
lung upper lobe apical-posterior deficiency; and the third clinical condition
was lung perfusion with the right lower lobe lateral basal deficiency. The
lung phantom was scanned at six planar views. These planar images are
shown in Figure 4.9.
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Figure 4.9: Lung perfusion images of three clinical conditions simulated
using the lung phantom. Six planar views were acquired for each scan.
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Clinical condition 1 = lung perfusion without deficiency; Clinical condition
2 = lung perfusion with the left lung upper lobe apical-posterior deficiency;
and Clinical condition 3 = lung perfusion with the right lower lobe lateral
basal deficiency.

A close-ended Likert-scale survey (see Appendix A) was conducted to gauge
the image quality of the planar perfusion images generated using the
phantom. Ten Nuclear Medicine physicians from various institutions6
participated in the study. The survey was conducted on a paper-based
format and on an online-based format7. Participants were required to score
each question with a suitable score value as listed in Table 4.5. The score
values are the same as used by Heikkinen et al. in their published article
(101). The questions of the questionnaire survey are as listed in Table 4.6.

The institutions are: Wollongong Hospital, Australia, St Vincent’s Private Hospital,
Australia, Peter McCallum Cancer Care Centre, Australia, Theranostics Centre for
Molecular Radiotherapy and Molecular Imaging, Germany, Hospital Universiti Sains
Malaysia, Malaysia, Hospital Kuala Lumpur, Malaysia, and Pusat Perubatan Universiti
Malaya, Malaysia.
7 http://booroo.com/app/rendersurvey.asp?sid=bj5jya9iebg5xg031784
6
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Table 4.5: The Likert-scale score values of the quality of planar perfusion
images generated using the anatomical lung phantom

1

Image
quality
Poor

2

Average

3

Satisfactory

4

Good

5

Excellent

Score

Specification
Not adequate for clinical application.
Barely adequate for limited clinical
application.
Adequate for clinical but not for exact
scientific application.
Adequate for clinical and exact
scientific application.
Excellent for clinical and scientific
application.

Table 4.6: List of questions incorporated in the questionnaire survey
Number

Question
How well do the lung perfusion images sets (Figure 4.9)
represent actual anatomical orientation of a lung

Question 1
perfusion planar image set of a suspected PE patient
with the indicated clinical condition?
How well do the lung perfusion image sets (Figure 4.9)
represent actual anatomical location of a lung
Question 2
perfusion planar image set of a suspected PE patient
with the indicated clinical condition?
How well do the lung perfusion image sets (Figure 4.9)
represent actual anatomical shape of a lung perfusion
Question 3
planar image set of a suspected PE patient with the
indicated clinical condition?
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According to Jamieson, Likert-type rating scales fall within the ordinal
level of measurement (102). The median or mode shall be used as a
‘measure of central tendency’ of ordinal data (102). Therefore, mode scores
were chosen as a measure of central tendency’ in this part of the study.
The mode scores of the study are shown in Figure 4.10.
5
Mode score
4

4

Score
3

3

3

2
0

1

2

3

Question

Figure 4.10: The chart shows the mode scores of the image quality of lung
images in Figure 4.9.

A small sample size (SS=10) generates a large margin of error (104-105).
Certainly, the statistical power of the study is low.

Nevertheless, the

survey results provide a valuable snapshot of Nuclear Medicine physicians’
perspective of the lung phantom. The project was not aimed to be
conducted as clinical trials with enrolment of large number of Nuclear
Medicine physicians. The study was conducted to investigate the quality of
end products of the phantom (lung scan images). Completion of the survey
indicates that Nuclear Medicine physicians are able to identify lung
perfusion defects modelled using the phantom.
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The mode scores were used to summarise the central tendency of responses
in this study. The higher the mode score (MS), the better quality is the
lung perfusion image set. It must be noted that results are more likely to
contain bias data as a result of using small a sample size.

The mode score of Question 1 was calculated based on the Nuclear
Medicine physicians’ responses to the anatomical orientation of the
planar perfusion Clinical condition 1 image set; the planar perfusion
Clinical condition 2 image set; and the planar perfusion Clinical condition
3 image set. The result of this question defines the ability of the anatomical
lung phantom to simulate the exact anatomical orientation of lung
perfusion scans of patients suspected having pulmonary embolism. The
mode score, MS, was 4 on a scale of 1 (poor) to 5 (excellent). The mode score
shows that the anatomical orientation of planar images generated using
the phantom are at high quality to be used for clinical studies or for
scientific studies.

The mode score of Question 2 was calculated based on the Nuclear
Medicine physicians’ responses to the anatomical location of the planar
perfusion Clinical condition 1 image set; the planar perfusion Clinical
condition 2 image set; and the planar perfusion Clinical condition 3 image
set.

The result of this question defines the ability of the anatomical lung

phantom to simulate the accurate anatomical location of a particular
lung perfusion deficiency. The mode score, MS, was 3 on a scale of 1 (poor)
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to 5 (excellent). The mode score shows that the quality of anatomical
location of a particular lung perfusion deficiency event (cold spot)
simulated using the phantom is at medium quality to be used for clinical
studies or for scientific studies.

The Question 3 mode score was calculated based on the Nuclear Medicine
physicians’ responses to the anatomical shape of the planar perfusion
Clinical condition 1 image set; the planar perfusion Clinical condition 2
image set; and the planar perfusion Clinical condition 3 image set.

The

shapes shall resemble planar perfusion scan images of patients suspected
with pulmonary embolism. The mode score, MS, was 3 on a scale of 1
(poor) to 5 (excellent). The mode score shows that the anatomical shapes of
planar perfusion images simulated using the phantom are at medium
quality to be used for clinical studies, not for exact scientific studies.

4.6 Reproducibility
Accuracy and reproducibility are very important characteristics of
phantoms used for clinical studies (106). One of the thesis goals was to
evaluate the reproducibility of lung perfusion images generated using the
anatomical lung phantom. To do this, three lung perfusion defect
conditions were simulated using the phantom.

The first condition

(Condition 1) was lung perfusion without deficiency; the second condition
(Condition 2) was lung perfusion with the left lung upper lobe apical-
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posterior deficiency; and the third clinical condition (Condition 3) was lung
perfusion with the right lower lobe lateral basal deficiency. Three planar
perfusion scans were acquired for each condition, allowing repetition.
Repetition of the acquisition allows a comparison to be made between
planar perfusion image sets having the same lung perfusion condition. All
planar images are shown in Figure 4.11 to Figure 4.13.
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Figure 4.11: Three lung perfusion scans of lung perfusion Condition 1. Each
scan was acquired independently.
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Figure 4.12: Three lung perfusion scans of lung perfusion Condition 2. Each
scan was acquired independently.
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Figure 4.13: Three lung perfusion scans of lung perfusion Condition 3. Each
scan was acquired independently.
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A close-ended Likert-scale (see Appendix B) survey was conducted to study
the reproducibility quality of the planar perfusion images generated using
the phantom (Figure 4.11 to Figure 4.13). Participants of the survey were
required to rate the reproducibility quality of the phantom based on the
ranking scales in Table 4.7.

The score values were re-modelled score

values as used by Heikkinen et al. in their published article (101). The
results are shown in Figure 4.14. Ten Nuclear Medicine physicians from
various institutions8 participated in this study. The survey was conducted
on a paper-based format and on an online-based format9.

Table 4.7: The Likert-scale score values of reproducibility quality of planar
perfusion images generated using the anatomical lung phantom

Score

Image
quality

1

Poor

2
3
4

5

Specification
The results show an inadequate reproducibility
standard of lung perfusion imaging.

The results show an acceptable reproducibility
standard of lung perfusion imaging.
The results illustrate an adequate reproducibility
Satisfactory
standard of lung perfusion imaging.
The results show a precise reproducibility
Good
standard of lung perfusion imaging.
Average

Excellent

The results show an outstanding reproducibility
quality of lung perfusion imaging.

The institutions are: Wollongong Hospital, Australia, St Vincent’s Private Hospital,
Australia, Peter McCallum Cancer Care Centre, Australia, Theranostics Centre for
Molecular Radiotherapy and Molecular Imaging, Germany, Hospital Universiti Sains
Malaysia, Malaysia, Hospital Kuala Lumpur, Malaysia, and Pusat Perubatan Universiti
Malaya, Malaysia.
9 http://booroo.com/app/rendersurvey.asp?sid=bj5jya9iebg5xg031784
8
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Figure 4.14: The chart shows mode scores of the reproducibility
questionnaire survey’s results.

As discussed earlier (see Section 4.5), according to Jamieson, Likert-type
rating scales fall within the ordinal level of measurement (102). Median or
mode shall be used as a ‘measure of central tendency’ of ordinal data (102).
Therefore, mode scores were chosen as a ‘measure of central tendency’ in
this part of the study.

The higher the mode score (MS), the better the quality of the lung
perfusion image set. Thus, a ‘poor’ statement is responding to an
unfavourable reproducible quality and an ‘excellent’ statement is
responding to a favourable reproducible quality. The participants were
required to score the five points Likert-style questions on scale 1 (poor) to 5
(excellent). Sample size, SS = 10 is acceptable in this study as it was not
conducted as clinical trials with enrolment of large number of Nuclear
Medicine physicians. The survey was conducted with aim to investigate
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Nuclear Medicine physicians’ overview of reproducibility quality of the
phantom.

The reproducibility is an important criteria used to quantify the degree
that the repeated acquisition process produced identical results (i.e., planar
perfusion images). The phantom reproducibility quality is medium (MS =
3) when it was used to generate three planar perfusion image sets with
Condition 1. The reproducibility quality is above medium-to-nearly high
(MS = 4) when it was used to simulate three planar perfusion image sets
with Condition 2. The phantom reproducibility quality is medium (MS = 3)
when it was used to generate three planar perfusion image sets with
Condition 3. As a conclusion, the anatomical lung phantom was able to
reproduce planar perfusion images at the least in medium reproducibility
quality.

103

5. QUALITY ASSURANCE STUDY
In this chapter, the study’s findings were presented in a journal article
format. Two manuscripts were prepared using materials from this chapter.
The two manuscripts entitled: ‘The use of revised PIOPED criteria in
reporting probability of PE of phantom’s generated planar perfusion
images’; and ‘Interpretation of mismatch defect size of phantom-generated
planar lung perfusion images by Nuclear Medicine physicians, are
currently under review by two peer reviewed journals.

5.1 Abstract
Quality assurance in nuclear medicine imaging is essential to ensure a
reliable imaging diagnosis. Nuclear Medicine physicians’ interpretation of
medical images must be of a consistently high quality as physicians make
initial treatments on the basis of the imaging interpretation.

In this work, a quality assurance study was conducted to assess diagnostic
accuracy in suspected PE by Nuclear Medicine physicians based on the
revised Prospective Investigation of Pulmonary Embolism Diagnosis
(PIOPED) criteria. An anatomical lung phantom with 18 separable lung
perfusion inserts manufactured at the University of Wollongong, NSW was
used to model lung perfusion images of patients suspected with pulmonary
embolism. A blinded quality assurance test was conducted to compare
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Nuclear Medicine physicians’ interpretations of the acquired lung perfusion
images. Ten Nuclear Medicine physicians participated in study. Each
acquired planar lung perfusion image set containing one or more segmental
defects. There were a number of incorrect diagnoses made by the Nuclear
Medicine physicians. The interpretation criteria have thin probability
borderlines (low probability borderline to intermediate probably borderline
to high probability borderline) of PE. Nuclear Medicine physicians are more
cautious when interpreting lung perfusion and ventilation scans that fall
close to these borderlines.

Keywords:

Lung perfusion, Quality assurance, Pulmonary Embolism.
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5.2 Introduction
Overview
The lung perfusion and ventilation scans is one of many diagnostic imaging
methods available for use in PE management (107). Lung perfusion and
ventilation planar imaging remains a significant pathway in PE
management in many nuclear medicine departments (26, 57, 107-109), as
it is considered less expensive than other methods (110).

PE is not always diagnosed because the condition can cause vague and non
specific symptoms (111). Mountain et al. reports that many Nuclear
Medicine physicians express a fatalistic approach managing pulmonary
embolism. At Mountain et al. institution, less than 50% of 400 reviewed
cases had a definitive diagnosis, with each case diagnosed after an initial
PE test (112). In their article, the authors reported that complete
investigations to confirm or exclude the PE diagnosis often do not occur.
The authors also stated that over three decades 70% of patients who died of
PE were misdiagnosed (112).

Quality assurance in medical imaging is implemented to ensure that
radiology examinations are appropriate, that necessary image is obtained,
that the correct interpretation is made, and that radiation cost and
exposure are minimal (113). A quality assurance program depends on all
members of the facility staff: imaging physician; medical physicist;
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technologist; clerical personnel; nurses and other employees (114). Testing
of misinterpretation of medical images has been suggested as part of the
medical imaging quality assurance process (115).

Magnussen et al., reported in their article that there are limited
investigations carried out to study the accuracy of lung scintigraphy
interpretation (116). In the article, they reported that the accuracy of lung
scan reporting is a difficult goal to achieve in vivo because a real gold
standard for this does not exist (116). They have created a virtual
scintigraphic model of the segmental anatomy of the human lungs. The
model has precise defect size and location. The model was used a tool to
investigate accuracy and intraobserver agreement in reporting lung
scintigraphy defect size (116).

A study was conducted to evaluate the accuracy of Nuclear Medicine
physicians’ sensitivity:
1. to the number of mismatch defects present on lung scans;
2. to the size of mismatch defects according to the revised PIOPED
criteria;
3. to probability of PE according to the revised PIOPED criteria.

The revised PIOPED criteria
A European Association of Nuclear Medicine (EANM) report suggested
that interpretation of lung V/Q SPECT and lung V/Q planar images should
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be based on: basic reference criteria, experience of the interpreter according
to the principle of “Gestalt” (62) and pretest probability with the principle
of Holistic interpretation (54). There are a number of lung perfusion and
ventilation planar interpretation reference criteria sets: the revised
PIOPED criteria (59-60), the Hull criteria (61) and the Gestalt
interpretation (62). In Gestalt interpretation, expert Nuclear Medicine
physicians interpret lung scans accurately based on their experience (62).
The Hull criteria and the revised PIOPED criteria have major differences
in terms criteria to classify probability of PE. In this study, the revised
PIOPED criteria was used to study Nuclear Medicine physicians’
interpretations of lung perfusion scans for PE diagnosis. The revised
PIOPED criteria are presented as a summary in Table 5.1.
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Table 5.1: The revised PIOPED criteria(59-60).
≥ 2 large10 mismatch defects
or
1 large mismatch defect and ≥2 moderate mismatch
defects
or
≥ 4 moderate11 mismatch defects
Intermediate
1 large mismatch defect ± 1 moderate mismatch
probability
defect
or
1-3 moderate mismatch defects
or
1 mismatch defect with normal X-ray12
Low probability
≥ 1 perfusion defect (match defect) with «13 X-ray
defect
or
Perfusion
defects
due
to
pleural
effusion,
cardiomegaly, enlarged aorta, hilum, mediastinum
and elevated diaphragm.
or
≥ 1 small14 perfusion defect with normal X-ray
or
≥ 2 mismatch defects with normal X-ray and some
areas of normal perfusion in lung
Normal probability No perfusion defect. Perfusion outlines exactly the
shape of the lung as seen on the chest radiograph.
High probability

Quality assurance: Size of V/Q mismatch defect
The size of V/Q mismatch defects is used within the revised PIOPED
interpretation criteria to assess the probability of pulmonary embolism.
According to the criteria, the size of mismatch defects are classified as

Large = mismatch defect ≥ 75% of a bronchopulmonary segment volumetric size
Moderate = mismatch defect = 25% to 75% of a bronchopulmonary segment volumetric
size
12 X-ray = Radiographic abnormality in region of perfusion abnormality
13 « = with a lot less
14 Small = mismatch defect ≤ 25% of bronchopulmonary segment volumetric size
10
11
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small (<25% of a bronchopulmonary segment), moderate (25%-75% of a
bronchopulmonary segment), or large (>75% of a bronchopulmonary
segment). In the revised PIOPED criteria, a single large defect is
considered as one segmental mismatch defect; a single moderate defect is
equivalent to 0.5 segmental mismatch defect (60, 117).

The segmental

equivalent of any mismatch defects is an important concept in the revised
PIOPED criteria. Any size of mismatch defects are added together to
increase the probability of PE (118).

The PIOPED investigator team reported majority of patients with PE do
not have high probability lung scans (119). A reason for that might be
underestimate size of mismatch defects by interpreter while reading lung
scans (120). The revised PIOPED criteria is a little complicated to use as
certain bronchopulmonary segments are smaller (in term of volumetric
size) than others. All bronchopulmonary segments of the left lung and the
right lung are not equal in size (volumetric) (121). The size of mismatch
defects on lung scans may not be consistent to true bronchopulmonary
segments’ natural size (120). Therefore, a mismatch defect that has been
interpreted as a small mismatch defect might in fact being one large
mismatch defect, or vice versa.

Quality assurance: Probability of pulmonary embolism
It is essential to accurately confirm or exclude the diagnosis of PE in its
management. This has been reportedly missing in PE diagnosis via lung
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scintigraphy because the method does not exclude or confirm the diagnosis
of PE in the majority of suspected patients (122). Murchison et al. stated in
their published article that several studies have shown that there are a
significant number of lung scintigraphy scans (39% in the PIOPED study)
where PE is either diagnosed or excluded (123). In the revised PIOPED
criteria, number of present mismatches defects has a significant impact on
the probability of pulmonary embolism.

As the number of present

mismatch defects increase, the probability of PE increases accordingly
(refer the revised PIOPED criteria) (60).

5.3 Materials and methods
Quality assurance: Size of mismatch defect
A similar study as published by Magnussen et al., (116, 124) was
conducted. The purpose of this study was to evaluate the Nuclear Medicine
physician diagnosis interpretations of mismatch defect size according to the
revised PIOPED criteria. In this study, different materials and methods
were employed compared to the study published by Magnussen et al.

In this study, an anatomical lung phantom was used to generate lung
perfusion images (48). The phantom was specially designed to model lung
perfusion defects circumstances depicted in lung perfusion scans. The
phantom consists of two lung cavities; and 18 perfusion defect inserts (48).
The perfusion defect inserts are complete bronchopulmonary segments of
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the human lungs. These inserts were employed as perfusion defects;
simulating perfusion absence in lung perfusion scans. The manufactured
phantom is able to simulate segmental lung perfusion deficiencies
(vascular segmental deficiencies) depicted in a typical lung perfusion scan
of patients with suspected pulmonary embolism.

Additional

perfusion

defect

inserts

with

size

25-75%

of

a

bronchopulmonary segment were manufactured for this study. The
additional perfusion defect inserts were manufactured using the same
negative moulds (refer section 3.5) created to manufacture the initial
perfusion defect inserts. Each mould was filled with water to identify its
volume in millilitre. The moulds were then filled with polyester resin up to
25-75% of its volumetric capacity, created perfusion defect inserts with size
25-75% of a bronchopulmonary segment.

To generate planar lung perfusion images, a perfusion defect insert was
fitted into the lung phantom. Next, an appropriate activity (approximately
40-50 MBq) of 99mTc solution was added into the assembled phantom. Then,
the phantom was scanned using planar imaging. The planar perfusion was
acquired at the 140 keV photopeak. In each planar scan, six planar views
were acquired in a 256 x 256 matrix: anterior (A), posterior (P), left
anterior oblique (LAO), left posterior oblique (LPO), right posterior oblique
(RPO) and right anterior oblique (RAO). The planar perfusion image set
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was then printed on a film. Then, the phantom was disassembled-thenassembled to prepare it for another planar scan.

Six perfusion defects at varied sizes were modelled using the anatomical
lung phantom with planar imaging. The lung perfusion defect images
generated using the phantom were assumed as V/Q mismatch defects as
depicted in lung scintigraphy. The lung scans that were presented to the
Nuclear Medicine physicians are shown in Figure 5.1. The six planar
perfusion events are:
1. Embolic event 1: Moderate mismatch defect within the right lung
upper lobe posterior segment.
2. Embolic event 2: Moderate mismatch defect within the left lung
lower lobe posterior basal segment.
3. Embolic event 3: Moderate mismatch defect within the left lung
lower lobe lateral basal segment.
4. Embolic event 4: Large mismatch defect within the left lung lower
lobe superior segment.
5. Embolic event 5: Large mismatch defect within the left lung upper
lobe anterior segment.
6. Embolic event 6: Large mismatch defect within the left lung upper
lobe lingular superior segment.
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Figure 5.1: Lung perfusion images of six embolic events modelled using the
anatomical lung phantom.

A blind test (see Appendix C) was conducted to compare Nuclear Medicine
physicians’ interpretations of mismatch defects’ size on the planar lung
perfusion images. All of the obtained images were presented to ten
experienced Nuclear Medicine physicians. Details of the mismatch defects
were not disclosed to the physicians. The physicians were asked to
categorise the mismatched defects based on its size; i small (<25% of a
bronchopulmonary segment); ii (25-75% of a bronchopulmonary segment);
or iii (>75% of a bronchopulmonary segment). These are the categories
used in the revised PIOPED criteria (59-60, 119).
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Quality assurance: Probability of pulmonary embolism
The anatomical lung phantom was also used to model lung perfusion
images for this quality assurance test (48). A blind test (see Appendix D)
was conducted to study the accuracy of Nuclear Medicine physicians’
interpretations of lung perfusion scan for PE diagnosis using the revised
PIOPED criteria. Six lung perfusion conditions were modelled using the
anatomical lung phantom with planar imaging. The planar perfusion
images of C 1 – C 6 are shown in Figure 5.2. There perfusion conditions
are:
1. C 1: Lung perfusion defect within the left lung upper lobe anterior
segment (large defect).
2. C 2: Lung perfusion defect within the left lung upper lobe anterior
segment (large defect) and lingular inferior segment (large defect).
3. C 3: Lung perfusion defect within the right lung upper lobe lateral
segment (large defect) and posterior segment (moderate defect).
4. C 4: Lung perfusion defect within the left lung lower lobe lateral
basal segment (large defect).
5. C 5: Lung perfusion defect within the right lung upper lobe anterior
segment (large defect);
6. C 6: Lung perfusion defect within the whole right lung upper lobe.
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(caption is on the next page)
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Figure 5.2: Planar images show lung perfusion defects image sets of six
embolic events. All lung perfusion defects were assumed mismatch defects.
The lung scans were acquired at six planar projections: anterior (A);
posterior (P); left anterior oblique (LAO); left posterior oblique (LPO); right
posterior oblique (RPO); and right anterior oblique (RAO).

The perfusion defect inserts used to model segmental defects are
components of the lung phantom (48). Nuclear Medicine physicians were
informed that all the visible lung perfusion defects were in fact V/Q
mismatch defects associated with a normal X-ray (in the region of
perfusion abnormality). Other information regarding the lung perfusion
image sets were not provided to the Nuclear Medicine physicians. The
physicians were given: i six lung perfusion image sets; ii the revised
PIOPED criteria; and iii an answer sheet. The answer sheet (see Figure
5.3) contains series of questions with empty spaces to be filled by the
physicians. The answer sheet provided in this chapter is a simplified
version of the answer sheet provided to the physicians. The physicians
were instructed to fill in the answer sheet based on: i the revised PIOPED
criteria; and ii their experience as Nuclear Medicine physicians. There
were ten Nuclear Medicine physicians from various institutions15 involved

The institutions are: Wollongong Hospital, Australia, St Vincent’s Private Hospital,
Australia, Peter McCallum Cancer Care Centre, Australia, Theranostics Centre for
Molecular Radiotherapy and Molecular Imaging, Germany, Hospital Universiti Sains
Malaysia, Malaysia, Hospital Kuala Lumpur, Malaysia, and Pusat Perubatan Universiti
Malaya, Malaysia.
15
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in this study. The study was conducted on a paper-based format and on an
online-based format16.

C1

Number of
present defects
.......................

Defects' size
......................

Probability of PE
...........................
.

C2

Number of
present defects
.......................

Defects' size
......................

Probability of PE
...........................
.

C3

Number of
present defects
..............

Defects' size
......................

Probability of PE
..........................
..

C4

Number of
present defects
.......................

Defects' size
......................

Probability of PE
...........................
.

C5

Number of
present defects
.......................

Defects' size
......................

Probability of PE
...........................
.

C6

Number of
present defects
.......................

Defects' size
......................

Probability of PE
...........................
.

NMP ....

Figure 5.3: The horizontal hierarchy shows the blind test’s answer sheet.
Nuclear Medicine physicians were required to report: i number of visible
mismatch defects on each embolic event; ii size the mismatch defects based
of the PIOPED criteria; and iii probability of PE based on the revised
PIOPED criteria.

PE = pulmonary embolism; and NMP

medicine physician.

5.4 Results
Quality assurance: Size of V/Q mismatch defect

16

http://booroo.com/app/rendersurvey.asp?sid=bj5jya9iebg5xg031784

= nuclear
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The planar views selected for the study were selected at where the
mismatch defects are at its largest (120). The physicians were informed
that lung perfusion defects (see Figure 5.1) generated using the phantom
were assumed as V/Q mismatch defects. The results of the blind test are
listed in Table 5.2.

Table 5.2: This table lists Nuclear Medicine physicians’ answers to the blind
test study. The physicians were asked to categorise the mismatch defects size
in Figure 5.1 according to the revised PIOPED (59-60, 119) criteria.

EE
actual
size
NMP18 1
NMP 2
NMP 3
NMP 4
NMP 5
NMP 6
NMP 7
NMP 8
NMP 9
NMP 10

EE17 1

EE 2

EE 3

EE4

EE5

EE 6

Moderate

Moderate

Moderate

Large

Large

Large

Moderate
Moderate
Large
Moderate
Moderate
Moderate
Moderate
Large
Large
Moderate

Large
Large
Large
Moderate
Moderate
Moderate
Large
Large
Large
Moderate

Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Moderate

Large
Moderate
Large
Large
Large
Large
Large
Large
Large
Moderate

Moderate
Small
Large
Moderate
Large
Large
Moderate
Moderate
Moderate
Large

Large
Moderate
Moderate
Small
Large
Moderate
Moderate
Large
Small
Moderate

The planar perfusion scans of Embolic event 1, Embolic event 2, and
Embolic event 3 were repeated with defects equal to 100% of a single
bronchopulmonary segment. This was done to give readers a clear view on
how size of perfusion defect affects the scan outcome (planar perfusion
images). The comparison of perfusion defects’ size of Embolic event 1,
17
18

EE = Embolic Event
NMP=Nuclear Medicine physician’s answer
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Embolic event 2, and Embolic event 3 are shown in Figure 5.4. Please note,
in this study, Figure 5.4 was not presented to the Nuclear Medicine
physicians.

Figure 5.4: Lung perfusion images of Embolic event 1, Embolic event 2, and
Embolic event 3, were simulated twice: at moderate size; and at large size
(for the benefit of the reader). The first column contains lung perfusion
images with moderate size defects according to the revised PIOPED criteria
(25-75% of a bronchopulmonary segment). The second column contains lung
perfusion images with large size defects according to the revised PIOPED
criteria (>75% of a bronchopulmonary segment).
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Quality assurance: Probability of pulmonary embolism
Each planar perfusion image set in Figure 5.2 contains one or more
segmental perfusion defects. The answers to the blind test questions were
summarised, shown in Figure 5.5.

Figure 5.5: Number of Nuclear Medicine physicians that have made correct
and incorrect interpretation on: i number of present mismatch defects; ii
size of mismatch defects; and iii probability of PE on based on the revised
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PIOPED criteria. The bar charts were created based on the nuclear
physician answers to the blind test questions.

5.5 Discussion
Quality assurance: Size of mismatch defect
The accuracy of mismatch defect size categorisations by the physicians
were summarised, shown in Figure 5.6.

Figure 5.6: The bar chart illustrates number of the Nuclear Medicine
physicians whom had correctly and incorrectly categorised (according to the
revised PIOPED (59-60, 119) criteria) the V/Q mismatch defects shown in
Figure 5.1

Size of the mismatch defect in embolic event 2 and embolic event 5 were
categorised incorrectly by six Nuclear Medicine physicians. Three of the
Nuclear Medicine physicians incorrectly categorised the size of mismatch
defect of embolic event 1. Two Nuclear Medicine physicians have
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incorrectly categorised the size of mismatch defect of embolic event 4.
Seven Nuclear Medicine physicians incorrectly categorised the size of
mismatch defect of embolic event 6. All Nuclear Medicine physicians have
correctly categorised the mismatch defect size of embolic event 3. The
number of incorrect mismatch defect size categorisations by nuclear
medicine physician is an interesting outcome. Correct size categorisation of
mismatch defect is essential in the revised PIOPED criteria (59-60, 119).

This study confirms Magnussen et al. works that segmental defect sizes
are sometime underestimated (116, 124). Nuclear Medicine physicians are
expected to familiarise themselves with the nature and size of
bronchopulmonary segments in order to diagnose PE from lung
scintigraphy. Accurate interpretation is an essential skill for these
physicians (125).

Quality assurance: Probability of pulmonary embolism
The bar chart in Figure 5.5(a) shows that two Nuclear Medicine physicians
made an incorrect interpretation on the number of mismatch defects seen
on C 5. However, all the Nuclear Medicine physicians had correctly
diagnosed the probability of PE on C 5.

The bar chart in Figure 5.5(b) shows ten Nuclear Medicine physicians have
made incorrect interpretations on the size of mismatch defects seen on C 1.
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However the probability of PE of C 1 was correctly diagnosed by all the
Nuclear Medicine physicians.

The bar chart in Figure 5.5(b) shows that two Nuclear Medicine physicians
made incorrect interpretations on the size of mismatch defects seen on C 5.
Yet, probability of PE of C 5 was correctly diagnosed by all the Nuclear
Medicine physicians.

Eight Nuclear Medicine physicians had incorrectly categorised the size of
one of the defects on C 3. There are two defects on planar image C 3: i a
large perfusion defect within the right lung upper lobe lateral segment; and
ii a moderate perfusion defect within the right lung upper lobe posterior
segment. The physicians categorised the moderate perfusion defect on C 3
as one large perfusion defect. This mistake lead to the incorrect evaluation
of probability of PE of C 3 based on the revised PIOPED criteria. Eight
physicians had incorrectly categorised the probability of PE of C 3 (see
Figure 5.5(c)).

The study was conducted to evaluate the quality assurance of Nuclear
Medicine physicians’ interpretations of lung perfusion images based on the
revised PIOPED criteria. The results show that Nuclear Medicine
physicians had occasionally made incorrect interpretations on a number of
present mismatch defects and their size on lung perfusion image sets.
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These interpretations are important in the revised PIOPED criteria, in
order to correctly categorise the probability of PE.

Two of the physicians had correctly categorised the probability of PE of C 5,
with incorrect justification on a number of present mismatch defects seen
on the planar perfusion image set. The two physicians had correctly
categorised the probability of PE of C 5, accompanied by a poor justification
on size of the present mismatch defects. Ten of the physicians had correctly
diagnosed PE probability of C 1 even though prior to the diagnosis, they
had incorrectly interpreted the size of the present mismatch defects seen
on the planar perfusion image set.

This quality assurance study shows that Nuclear Medicine physicians may
correctly categorise the probability of PE, even though the justifications
that grounded the diagnosis are poor. This is mainly because, the revised
PIOPED criteria have thin probability borderlines (low probability
borderline to intermediate probably borderline to high probability
borderline) of PE. Nuclear Medicine physicians that are using the revised
PIOPED criteria should be more cautious in interpreting lung V/Q scans
that fall close to the borderlines. This is to ensure strong justifications
support each PE diagnosis that is being made based on the revised
PIOPED criteria.
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5.6 Conclusion
Quality assurance: Size of mismatch defect
The study was conducted to evaluate the accuracy of Nuclear Medicine
physician’s diagnosis on V/Q mismatch defect size based on the revised
PIOPED criteria. The results show that a few Nuclear Medicine physicians
had underestimated the size of mismatch defects. Morrell et al. suggested
that scoring criteria based on segmental size should be done with caution
(120). This will ensure the high quality of PE diagnosis via lung perfusion
and ventilation scans.

Quality assurance: Probability of pulmonary embolism
In the revised PIOPED criteria, the number of present mismatch defects
has a significant impact on the probability of PE. As the number of present
mismatch defects increases, the probability of PE increases (60). Also, the
criteria emphasises the significance of mismatch defects’ size in assessing
the probability of PE of any lung V/Q scans (59-60, 117, 119). Any size of
mismatch defects are to be added together to increase the probability of PE
(118).
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6. A LUNG PERFUSION IMAGING ATLAS
The findings of this chapter were previously presented as a poster in the
40th Annual Scientific Meeting of the Australian and New Zealand Society
of Nuclear Medicine. The abstract of the presentation was published in the
Internal Medicine Journal (126).This chapter was written in a journal
article format. This chapter was revised and edited creating a manuscript
entitled ‘Lung Perfusion Imaging Atlas for PE Diagnosis via Lung
Perfusion and Ventilation Scan’. The manuscript is currently under review
by a peer reviewed journal.

6.1 Abstract
Objective: A lung perfusion imaging atlas was manufactured at the
Department of Nuclear Medicine, Wollongong Hospital, NSW, Australia.
The atlas was developed with the aim of being used as a teaching aid; and
as a reference resource aid in interpreting lung perfusion and ventilation
scans. Nuclear Medicine physicians are expected to be the primary users of
the imaging atlas.
Methods: The anatomical lung phantom consists of two lung cavities and
18 separable lung perfusion inserts, and was used to develop the imaging
atlas. Single segmental perfusion defects depicted in lung perfusion scans
were modelled using the phantom with planar imaging and SPECT
imaging. Segmental perfusion defects were simulated by means of 18
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insertable

bronchopulmonary

segments

of

the

human

lungs.

A

questionnaire survey was conducted to study Nuclear Medicine physicians’
opinions on the imaging atlas.
Results: Planar and SPECT images were gathered in the compilation of
the lung perfusion imaging atlas. This atlas demonstrates the precise
appearance of segmental defects on a lung scan. All Nuclear Medicine
physicians agreed that the imaging atlas was a good teaching aid and a
reference resource for inexperienced Nuclear Medicine physicians who are
developing experience in the diagnosis of PE on lung perfusion and
ventilation images.
Conclusions: We hope that the atlas will increase new Nuclear Medicine
physicians understanding of lung bronchopulmonary segmental anatomy
in lung scans.

Keywords: Planar, SPECT, Lung perfusion, Imaging atlas, Pulmonary
Embolism
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6.2 Introduction
PE is one of commonly clinically misdiagnosed diseases in the United
States of America (127). Howarth et al. reported in their article that there
is, in general, poor understanding of the test results among referring
physicians (128). The fundamental rules of thumb to diagnose PE via lung
perfusion

and

ventilation

scan

are

to

identify

lobar,

segmental,

subsegmental perfusion and ventilation mismatch defects on lung
perfusion and ventilation image sets (54). All segmental and subsegmental
perfusion defects are considered significant at a minimum of 25%
volumetric size of a lung bronchopulmonary segment (60, 128). With all the
established methods to diagnose PE via lung scans, the disease remains
challenging to diagnose, resulting in many nonconclusive diagnoses (129).
Experienced Nuclear Medicine physicians were reported having difficulty
in identifying the size of particular lung perfusion defects (120).
Underestimation of lung perfusion defects size may lead to incorrect PE
diagnosis. Therefore, this study was carried out to introduce an imaging
atlas as a reference resource and a teaching aid for interpreting lung
perfusion and ventilation scans. The atlas was generated with the hope of
assisting Nuclear Medicine physicians in diagnosing PE via lung perfusion
and ventilation scans.
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6.3 Materials and methods
An anatomical lung phantom (48) was used throughout this study. The
phantom was uniquely developed to model the lung perfusion conditions of
patients with suspected pulmonary embolism. The phantom consists of 18
perfusion defect inserts. These inserts are complete bronchopulmonary
segments of the human lungs. They were employed as perfusion defects
simulating perfusion absence in lung perfusion scans. On the whole, the
manufactured phantom is able to simulate segmental lung perfusion
deficiencies (vascular segmental deficiencies) depicted in typical lung
perfusion scans of patients with suspected pulmonary embolism.

The study was carried out to model single segmental perfusion defects
(100% volumetric size) of lung bronchopulmonary segments of the human
lungs. To generate the atlas, individual perfusion defect inserts were fitted
into the lung phantom. Then an appropriate activity (approximately 40-50
MBq) of

99mTc

solution was added to the assembled phantom. Next, the

phantom was scanned using planar imaging and SPECT imaging. Then,
the phantom was disassembled-then-re-assembled to prepare it for further
planar and SPECT scans. The process was repeated until 18 planar and
SPECT scans (of all 18 bronchopulmonary segments) were completed.

The atlas development process took approximately 13 weeks. The lung
phantom was scanned using a dual head gamma camera (Philips ADAC
Forte) at the Department of Nuclear Medicine, Wollongong Hospital, NSW,
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Australia. The scans were scheduled once or twice a week depending on the
availability of the camera.

Planar and SPECT acquisitions
In each planar scan, six planar views were acquired in a 256 x 256 matrix:
anterior (A), posterior (P), left anterior oblique (LAO), left posterior oblique
(LPO), right posterior oblique (RPO) and right anterior oblique (RAO). The
planar perfusion scans were acquired at the 140 keV photopeak. The
planar perfusion image set was then printed on x-ray film and stored
electronically on the hospital PACS.

In each SPECT scan, a step-and-shoot protocol of 12 s/3°step for a total of
60 views per camera head was used. Images were collected at the 140keV
energy window. Lung SPECT image sets were reconstructed using a
HERMES workstation (Hermes Medical Solutions, Stockholm, Sweden).
Reconstruction of coronal (from anterior to posterior), sagittal (from right
to left) and transverse (from head to feet) slices were done using FBP with
a Butterworth cut off value of 0.4. The images were stored in digital format
on the hospital PACS. SPECT images are viewed on the HERMES
workstation and also printed on x-ray film.

A close-ended Likert-scale survey
A small scale close-ended Likert-scale survey was conducted to obtain a
snapshot of Nuclear Medicine physicians’ opinions on the atlas to be used
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as a reference resource and a teaching material to interpret lung perfusion
and ventilation scans. The survey (Appendix E) was sent to ten Nuclear
Medicine physicians at various institutions19. The survey was conducted on
a paper-based format and on an online-based format20. The Nuclear
Medicine physicians were requested to score each question with the score
value listed in Table 6.1. The score values were re-modelled score values
used by Heikkinen et al. in their published article (101).

Table 6.1: Nuclear Medicine physicians were required to score each question
using the four-points Likert-scale as shown in the table
Score
1
2

Image Quality
Poor
Average

3
4

Good
Excellent

Specification
Not adequate for clinical application21
Barely adequate for limited clinical
application
Adequate for clinical application
Excellent for clinical application

The survey pack was divided into three parts:
1. Introduction (includes: summary of the anatomical lung phantom;
objectives of the survey);
2. The lung perfusion imaging atlas;
3. A series of close-ended questions.

The institutions are: Wollongong Hospital, Australia, St Vincent’s Private Hospital,
Australia, Peter McCallum Cancer Care Centre, Australia, Theranostics Centre for
Molecular Radiotherapy and Molecular Imaging, Germany, Hospital Universiti Sains
Malaysia, Malaysia, Hospital Kuala Lumpur, Malaysia, and Pusat Perubatan Universiti
Malaya, Malaysia.
20 http://booroo.com/app/rendersurvey.asp?sid=bj5jya9iebg5xg031784
21 Clinical application means aiding material to help Nuclear Medicine physicians
interpret lung perfusion and ventilation scans for pulmonary embolism diagnosis.
19
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The close-ended survey’s questions were:

1. As an experienced Nuclear Medicine Physician, how do you rate the
atlas’ suitability to be used as a reference resource and teaching aid
for new Nuclear Medicine physicians to develop experience in
interpreting lung V/Q mismatch defects for PE diagnosis?

2. What is your opinion on the atlas’ suitability to be used as a
reference (a reference material to experienced Nuclear Medicine
physicians) for anatomical bronchopulmonary segmental size and
structure (scintigraphic and tomographic) in PE diagnosis by lung
perfusion and ventilation scans?

3. What is your opinion on the atlas as an aid to interpret lung
perfusion and ventilation scans for PE diagnosis? We propose
Nuclear Medicine physicians use the atlas as an aid together with
standard interpretation criteria (the revised PIOPED criteria, the
Hull criteria or the Gestalt interpretation).

In this study, Nuclear Medicine physicians were informed that all the
visible lung perfusion defects were in fact V/Q mismatch defects with
associated with a normal chest x-ray (in the region of perfusion
abnormality).
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6.4 Results
All the planar and SPECT images were gathered together to comprise the
lung perfusion imaging atlas (see Figure 6.1 to Figure 6.18). The atlas only
contains single segmental lung perfusion defects images (planar and
SPECT) of 18 bronchopulmonary segments.

Figure 6.1: Planar and SPECT images of a perfusion defect within the
apical segment of the right upper lobe.
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Figure 6.2: Planar and SPECT images of a perfusion defect within the
posterior segment of the right upper lobe.
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Figure 6.3: Planar and SPECT images of a perfusion defect within the
anterior segment of the right upper lobe.
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Figure 6.4: Planar and SPECT images of perfusion defect within the lateral
segment of the right middle lobe.
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Figure 6.5: Planar and SPECT images of a perfusion defect within the
medial segment of the right middle lobe.
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Figure 6.6: Planar and SPECT images of a perfusion defect within the
superior segment of the right lower lobe.
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Figure 6.7: Planar and SPECT images of a perfusion defect within the
medial basal segment of the right lower lobe.
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Figure 6.8: Planar and SPECT images of a perfusion defect within the
anterior basal segment of the right lower lobe.
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Figure 6.9: Planar and SPECT images of a perfusion defect within the
lateral basal segment of the right lower lobe.
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Figure 6.10: Planar and SPECT images of a perfusion defect within the
posterior basal segment of the right lower lobe.
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Figure 6.11: Planar and SPECT images of a perfusion defect within the
apical and posterior segment of the left upper lobe.
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Figure 6.12: Planar and SPECT images of a perfusion defect within the
anterior segment of the left upper lobe.
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Figure 6.13: Planar and SPECT images of a perfusion defect within the
lingular superior segment of the left upper lobe.
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Figure 6.14: Planar and SPECT images of a perfusion defect within the
lingular inferior segment of the left upper lobe.
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Figure 6.15: Planar and SPECT images of a perfusion defect within the
superior segment of the left lower lobe.
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Figure 6.16: Planar and SPECT images of a perfusion defect within the
medial and anterior basal segment of the left lower lobe.
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Figure 6.17: Planar and SPECT images of a perfusion defect within the
lateral basal segment of the left lower lobe.
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Figure 6.18: Planar and SPECT images of a perfusion defect involving the
posterior basal segment of the left lower lobe.
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The survey results
This is a small scale survey with a small sample size (SS = 10). As
described earlier (see Section 4.5), a conclusion of a small sample size study
is unclear with wide uncertainty (103).

A small sample size generates

large margin of error (104-105). However, the total number of physicians
participated in this study is considered acceptable as the project was not
designed as a clinical study. The aim of the study was to investigate the
clinical value of the atlas to a small group of experienced Nuclear Medicine
physician. The following chart (Figure 6.19) shows the mode score of the

Mode score

survey study.

4
Mode score
3
2
1
0
0

1

2

3

Question

Figure 6.19: The chart shows mode scores of the survey.

As described earlier in Section 4.5, Likert-type rating scales fall within the
ordinal level of measurement (102). Median or mode shall be used as a
‘measure of central tendency’ of ordinal data (102). In this study, the mode
scores have been used as a measure of central tendency.
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The MS of the Question 1 was 3. The higher the mode score of Question 1,
the higher the quality of the information carried by the atlas for new
Nuclear Medicine physicians. The result shows that the atlas is of good
reference quality for new Nuclear Medicine physicians.

The MS of the Question 2 was 2. The higher the mode score of Question 2,
the higher the quality of anatomical information carried by the atlas for
experienced Nuclear Medicine physicians. The result shows that the atlas
supplies mediocre anatomical information to Nuclear Medicine physicians.

Finally, the MS of Question 3 was 2. The higher the mode score of Question
3, the higher the suitability of the atlas as an aid to interpret lung
perfusion and ventilation scan. The result shows that the atlas is an
unsuitable aid to interpret lung perfusion and ventilation scans for PE
diagnosis.

6.5 Discussion
The lung perfusion imaging atlas
A number of models representing human lung segmental anatomy have
been developed over the years. These models were based upon various
sources: phantom; volunteer subjects; and virtual models using Monte
Carlo simulation. Each model was developed with a specific aim and
purpose.
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In this study, the lung perfusion imaging atlas represents a comprehensive
segmental anatomy of the human lungs in three tomographic planes and in
planar views. The aim of the atlas development was to aid Nuclear
Medicine physicians in interpreting lung perfusion and ventilation scans.
Tomographic images were included in the atlas because many recent
publications have claimed that SPECT is superior to planar imaging for
the diagnosis of PE (57, 130-132).

Magnussen et al. developed a virtual model of the segmental anatomy of
the human lung. In that study 18 single segmental and 47 subsegmental
defects were simulated using Monte Carlo simulation. The defects were
displayed in tomographic planes and in eight planar views. Their model of
the segmental anatomy of a human lung was developed in order to
investigate the sensitivity of detection (planar versus SPECT), and
accuracy of estimation of defect size (55).

The tomographic images presented in our study are of similar quality
compared to the tomographic images simulated by Magnussen et al. Their
publication does not contain all the 18 single segmental defects of a typical
bronchopulmonary segment of the human lungs. In contrast, the present
study offers a complete segmental anatomy of a human lung in
tomographic planes and in planar views. Presenting the complete
segmental anatomy of the human lungs is the main objective of this study,
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in order to assist Nuclear Medicine physicians in their interpretation of
lung perfusion and ventilation scans.

Morrell et al., demonstrated appearances of known lobar and segmental
defects on lung scans (133). Their study, using healthy volunteers, was
carried out to suggest optimal positioning for visualization of a defect. They
successfully defined 18 segmental defects in a lung scan. Not all the
segmental defects’ images were included in their article which mainly
focussed on planar scintigraphy (133). In contrast, the lung perfusion
imaging atlas in the current study offers planar and SPECT images of all
18 single segmental defects of the human lungs.

Carbonell et al. constructed a lung-thorax phantom to aid lung
scintigraphic interpretation. The phantom was made of polyester (thorax)
and polyurethane (lung tissue). The segmental defects of the phantom do
not resemble true anatomic features of the human lungs (134). The lung
phantom used in the present study, as described in Kabir et al [48], was
exclusively designed to model single segmental defects of the human lungs.
The perfusion defect inserts carry true anatomical features of the human
lungs (48).

The survey results
The chart in Figure 6.19 (Question 1) shows that all nuclear medical
physicians agree that the atlas is a good reference for new Nuclear
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Medicine physicians. Although the anatomical representations of the atlas
is clinically limited, it is still a valuable material to inexperienced Nuclear
Medicine physicians that are developing experience in interpreting lung
perfusion images of lung perfusion and ventilation scans.

The survey’s results in Figure 6.19 (Question 2) confirm that the atlas
carries minimal anatomical information to aid experienced Nuclear
Medicine physicians in interpreting lung perfusion scans for PE diagnosis.

Finally, respondents were asked to score the atlas ability in assisting
Nuclear Medicine physicians to interpret lung perfusion and ventilation
scans for PE diagnosis (Question 3). The atlas was proposed to be used as
an aid material together with the standard interpretation criteria (the
revised PIOPED criteria, the Hull criteria and Gestalt interpretation) (6061, 135). The chart in Figure 6.19 shows that the atlas is an unsuitable aid
for Nuclear Medicine physicians to interpret lung perfusion and ventilation
scans for PE diagnosis.

6.6 Conclusion
According to survey study, experienced Nuclear Medicine physicians
confirmed that the atlas is a valuable reference resource and teaching
material for inexperienced Nuclear Medicine physicians. However, the
atlas has limited valuable anatomical information and barely benefits
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experienced nuclear medicine physician to diagnose PE on lung perfusion
and ventilation images.

The survey was conducted on a small scale with ten respondents.
Therefore, the statistical power of the survey is certainly low. However, the
survey’s results represent a valuable snapshot overview of the atlas, from
the perspective of experienced Nuclear Medicine physicians.
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7. WATER BATH ATTENUATION EFFECTS
ON LUNG PHANTOM PLANAR
ACQUISITION

7.1 Introduction
Realistic models of the human body have to take into account tissue
attenuation (136). The attenuation of gamma radiations in human tissue
is a critical factor during imaging (137). Currently available thoracic
SPECT phantoms were studied to initiate the development of a simulated
thoracic attenuation phantom for the anatomical lung phantom.

The importance of a thoracic cavity for a lung phantom has been
demonstrated by Heikkinen et al. (21). The researchers developed a lung
phantom to simulate a clinical ventilation-perfusion situation. The lung
phantom was inserted inside a physical chest cavity, to simulate the thorax
in any planar or SPECT scans. The lung phantom (not including perfusion
defect inserts) and the chest cavity are fully tissue equivalent. The
attenuation properties of the phantom closely resemble actual clinical
attenuation.

Doshi et al. reported the effects of the thorax background in breast cancer
scan simulations using Positron Emission Tomography (PET). Three
experimental designs were setup to study the role of object scatter and
attenuation

property

in

defining

image

signal-to-noise

ratio.

The
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experimental setups were: the breast phantom (with lesions) was scanned
without the thorax cavity; the breast phantom (with lesions) was scanned
with the thorax cavity filled with water without radioisotope; the breast
phantom (with lesions) was scanned with the thorax cavity filled with
realistic activity concentrations. The breast phantom when scanned with
the thoracic cavity filled with realistic activity was the closest achievable
simulation of breast cancer patient. The simplified phantom (breast
phantom scanned without the thorax cavity) does not provide a realistic
activity distribution, scatter or attenuation properties (138).

The thoracic cavity is recognised as an important part of the anatomical
lung phantom to provide better attenuation properties of any lung
perfusion scans. However, the thoracic cavity was neglected in the design
of our phantom. The justifications of not using thoracic background in this
thesis were:
1. to minimise the time taken to complete the research;
2. to minimise the cost of the research;
3. the preliminary lung perfusion scan simulations using the phantom
have been published in a peer reviewed journal and presented in
peer reviewed scientific meetings. These show that lung perfusion
images generated using the phantom (without the thoracic cavity)
are acceptable scientific studies;
4. experienced Nuclear Medicine physicians that participated in one of
the snapshot surveys confirmed that the lung perfusion images
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generated using the phantom are at of a medium quality. The
physicians also confirmed that the quality of lung perfusion images
generated using the phantom are suitable for any clinical studies.

The visual effects of a thoracic background on the lung phantom were
studied. A practical and economical non-radioactive thorax cavity was
developed to be used together with the lung phantom. A water-filled
container was chosen to simulate the thorax attenuation properties for the
lung phantom. In this study, the dimensions of an actual thoracic cavity
were not taken into account. Time and cost were two factors that limited
the development of a better thorax cavity for this study. However, the
water-filled container was still able to simulate the attenuation medium in
thoracic cavity.

Many researchers have used water to simulate thoracic cavity in their
radiology phantom studies. Sandborg et al. (139) in their published article
reported that water is a soft tissue equivalent material for test phantoms
in diagnostic-radiology. In an experiment by Doshi et al. (140), a thoracic
phantom was filled with cold water to simulate thoracic (background)
attenuator properties. Celler et al. (136) used a plastic cylinder (25 cm
high and 24.5 cm diameter) filled with as a substitute thorax for
quantitative dynamic functional imaging for SPECT.

160

7.2 Materials and methods
An experimental setup was designed to add attenuation medium effects on
the lung phantom scans (see Figure 7.1). The water bath was considered
as the thorax attenuation medium for 140 keV 99mTc gamma rays.

Figure 7.1: a Experimental set-up: the anthropomorphic lung phantom
submerged in water (red) on the gamma camera bed. b Dimensions of the
water bath.

Firstly, the left lung upper lobe superior perfusion defect insert was
installed into the phantom. The phantom was scanned with the planar
imaging protocol according to Kabir et al. (48).

Secondly, the phantom was placed in a rectangular container. The
container was then filled with water. The water was dyed red to easily
monitor leakage in the camera room (see Figure 7.1). Then, the phantom
was scanned with the planar imaging protocol according to Kabir et al.
(48).
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7.3 Results
The planar perfusion images of the phantom are shown in Figure 7.2. The
posterior view was chosen as it shows the perfusion defect at its largest.

Figure 7.2: a The planar posterior view of the anatomical lung phantom
scanned without the water bath. b The planar posterior view of the
anatomical lung phantom scanned with the water bath.

The intensity of the gray value of pixels around the edge of images in
Figure 7.2 were analysed using the ImageJ software. A selection tool of the
software was used to create region of interest (ROI) around the edges of
images (see Figure 7.3). The ROI of the planar perfusion image when the
lung phantom was scanned without the water bath was named ROI1; and
was named ROI2 for planar perfusion image when the lung phantom was
scanned with the water bath. The frequency distribution (histogram) of
pixel values (0-255) in ROI1 and ROI2 are shown in Figure 7.3b and Figure
7.3c respectively.
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Figure 7.3: a ROI1 is the edge of planar perfusion image of the lung
phantom without water-filled container. ROI2 is the edge of planar
perfusion image of the lung phantom with water-filled container. b
Frequency distribution of pixel value intensities (0-255) in ROI1. c
Frequency distribution of pixel value intensities (0-255) in ROI2.

In Figure 7.3b the mean is 133.8 and standard deviation is 63.8. The mean
is 134.9 and standard deviation is 49.6 respectively in Figure 7.3c. A much
smaller standard deviation recorded in Figure 7.3c means the pixel
intensity values in ROI2 lie closer around its mean value compared to
ROI1. The ROI2 perfusion defect edges are much softer compared to the
ROI1.
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7.4 Discussion
In Figure 7.1, the aqueous solution of

99mTc

in the lung phantom emits 140

keV gamma radiations as it decay. The gamma radiation interacted with; i
the aqueous solution of

99mTc

in the lung phantom, and ii water in the

bath. The gamma radiation interacts with water by photoelectric and
Compton scattering mechanisms (see Section 2.7). For energies between 50
keV to 550 keV, Compton scattering is the dominant interaction in
material with lower atomic number; for example soft human tissues
(atomic number = 7.5) (63). The combined effects of the Compton scattering
(dominant interaction) and photoelectric is termed attenuation (63).

Perfusion defect in lung perfusion scans are normally seen as areas of
decreased, rather than absent, (141-143), The edges of perfusion defect
region when the lung phantom scanned with the water bath (Figure 7.2b)
are softer, while the edges of the perfusion defect region when the lung
phantom scanned without the water bath (Figure 7.2a) are sharp. The
added attenuation medium generated planar perfusion images that more
closely resemble patients’ scintigraphic images.

7.5 Conclusion
In this thesis, the water bath was not included as part of the anatomical
lung phantom in Chapters 3 to 6. All the planar and SPECT acquisitions

164

were done without the thoracic background attenuation material (water
bath).

The findings in this chapter provide a positive indication that the image
quality of lung perfusion images closely resemble lung perfusion image of a
patient when the lung phantom was scanned with the water bath. Based
on the positive results in this chapter, the development of a tissue
equivalent thoracic cavity for the lung phantom is highly recommended in
future studies.
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8. CONCLUSION
8.1 Review of the thesis
The thesis has successfully demonstrated a method to design and to
develop a novel anatomical lung phantom. The lung phantom was
exclusively designed to model lung perfusion conditions of suspected PE
patients via planar or SPECT imaging. Initial studies showed that the lung
phantom was able to model clinical images of suspected PE phantom via
planar and SPECT imaging.

The lung phantom has a higher HU values compared to the human lungs.
The attenuation property of the lung phantom was compromised to permit
high quality anatomical structure of the phantom, as described in Chapter
3. The accuracy of anatomical representations of the lung phantom is a
crucial factor in this thesis. The physical material used to model lung
perfusion defects (lung bronchopulmonary segments) was able to closely
represent the shapes of the human lung. The distribution of

99mTc

radionuclide was analysed, and confirmed to be homogenous throughout
the lung phantom. The anatomical lung phantom was able to reproduce
planar perfusion images at of a medium reproducibility quality.
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A small scale quality assurance study was conducted with the lung
phantom used as the main tool. The results showed occasionally Nuclear
Medicine physicians make incorrect diagnosis of pulmonary embolism on
planar lung perfusion images using the revised PIOPED criteria.

A comprehensive lung perfusion imaging planar and SPECT atlas was
included in Chapter 6 of the thesis. Via a survey form, Nuclear Medicine
physicians were asked to comment on the efficacy of the atlas. Whilst the
statistical power of the study is low (due to small sample size), the results
are still considered as a valuable snapshot opinions (opinions on the atlas)
of experienced physicians. The physicians agreed that the atlas is a useful
reference resource and teaching material to inexperienced Nuclear
Medicine physicians.

Finally, use of a uniform water bath revealed the change in attenuation
affects the quality of lung planar perfusion images modelled using the lung
phantom. However, the water bath was not included in the research
project. Justifications for the decision were described in Chapter 7.

On the whole, this thesis has successfully addressed the main objective and
other minor objectives of the research.
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8.2 Future work
Following the thesis completion, the author plans to continue a number of
related projects related to the research including:
1. Remodel the lung bronchopulmonary segments (lung perfusion
defect inserts) using tissue equivalent materials. A further literature
study is needed to find a tissue equivalent material that is able to
better hold the anatomical shapes of human lung.
2. Design an attenuation-correct thoracic cavity that encloses the
anatomical lung phantom. The thoracic cavity shall provide
background attenuation property to the lung phantom.
3. Reconduct all the survey studies at a larger sample size in order to
produce statistically significant conclusions to the studies.
4. Develop more quality assurance studies concerning lung perfusion
and ventilation scans using the revised PIOPED criteria.
5. Compare the sensitivity of planar and SPECT imaging on lung
perfusion and ventilation scans for PE diagnosis using the
anatomical lung phantom.
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10. APPENDIXES

192
Appendix A
Lung Perfusion Image Evaluation 1: Anatomical properties
Introduction:
1. This survey contains questions relating to lung perfusion images of a lung phantom.
2. The phantom was manufactured for research purposes. The main objective of the research is to investigate Nuclear Medicine
Physician interpretive performance in evaluating lung perfusion images based on the revised PIOPED criteria. This current
survey was developed solely to seek Nuclear Medicine Physician opinion on the phantom’s representation of lung perfusion
imaging of patients with suspected pulmonary embolism.
3. The images are simulated scintigraphic images of a human lung perfusion scan with and without lung segmental perfusion
defects, and mimic a lung perfusion scan for suspected lung thrombolism patients. All perfusion defects are assumed as V/Q
mismatch defects.
4.

In a normal clinical lung V/Q scan, a perfusion defect appears as reduced or subsegmental perfusion. However, the images
generated by the manufactured phantom appear as absent lung perfusion defects.

5. The evaluation survey is divided into two parts.
i.

In the first part, a set of question are presented regarding three sets of lung perfusion images.

ii.

The second part, a blind test for Nuclear Medicine physicians, who are required to identify five different segmental
defects in lung perfusion images.
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Instruction:

Please score/answer all questions based on criteria given in Table A.

Table A
Score

Image quality

Specification

1

Poor

Not adequate for clinical application.

2

Average

Barely adequate for limited clinical application.

3

Satisfactory

Adequate for clinical but not for exact scientific
application.

4

Good

Adequate

for

clinical

and

exact

scientific

application.
5

Excellent

Excellent for clinical and scientific application.
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Part 1

Figure 1

195
Score
Questions – Figure 1

1

How well does the lung perfusion image set in Figure 1 represent the anatomical

1

2

3

4

5

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

orientation of a lung perfusion image set of a suspected pulmonary embolism patient with
the indicated clinical condition?
2

How well does the lung perfusion image set in Figure 1 represent the anatomical
location of a lung perfusion image set of a suspected pulmonary embolism patient with the
indicated clinical condition?

3

How well does the lung perfusion image set in Figure 1 represent the anatomical shape
of a lung perfusion image set of a suspected pulmonary embolism patient with the
indicated clinical condition?

4

How do you rate the overall ability of the image set in Figure 1 to represent a planar lung
perfusion image set of a patient having suspected pulmonary embolism?

196

Figure 2

197
Score
Questions – Figure 2

1

How well does the lung perfusion image set in Figure 2 represent the anatomical

1

2

3

4

5

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

orientation of a lung perfusion image set of a suspected pulmonary embolism patient with
the indicated clinical condition?
2

How well does the lung perfusion image set in Figure 2 represent the anatomical
position/location of a lung perfusion image set of a suspected pulmonary embolism
patient with the indicated clinical condition?

3

How well does the lung perfusion image set in Figure 2 represent the anatomical shape
of a lung perfusion image set of a suspected pulmonary embolism patient with the
indicated clinical condition?

4

How do you rate the overall ability of the image set in Figure 2 to represent a planar lung
perfusion image set of a patient having suspected pulmonary embolism?

198

Figure 3

199
Score
Questions – Figure 3

1

How well does the lung perfusion image set in Figure 3 represent the anatomical

1

2

3

4

5

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

o

orientation of a lung perfusion image set of a suspected pulmonary embolism patient with
the indicated clinical condition?
2

How well does the lung perfusion image set in Figure 3 represent the anatomical
position/location of a lung perfusion image set of a suspected pulmonary embolism
patient with the indicated clinical condition?

3

How well does the lung perfusion image set in Figure 3 represent the anatomical shape
of a lung perfusion image set of a suspected pulmonary embolism patient with the
indicated clinical condition?

4

How do you rate the overall ability of the lung perfusion image set in Figure 3 to represent
a planar lung perfusion image set of a patient having suspected pulmonary embolism?

200
Part 2

Figure 4

201
Questions – Figure 4

Answer

1 Figure 4 simulates a segmental lung perfusion defect in a patient with suspected
pulmonary embolism. Please specify the name of the defect segment.

……………………………............

How do you rate the overall ability of the lung perfusion image set in Figure 4 to represent
2 a planar lung perfusion image set of a patient with suspected pulmonary embolism?

Score
1

2

3

4

5

o

o

o

o

o
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Figure 5

203
Questions – Figure 5

Answer

1 Figure 5 simulates a segmental lung perfusion defect in a patient with suspected
pulmonary embolism. Please specify the name of the defect segment.

……………………………............

How do you rate the overall ability of the lung perfusion image set in Figure 5 to represent
2 a planar lung perfusion image set of a patient with suspected pulmonary embolism?

Score
1

2

3

4

5

o

o

o

o

o
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Figure 6

205
Questions – Figure 6

Answer

1 Figure 6 simulates a segmental lung perfusion defect of a patient with suspected
pulmonary embolism. Please specify the name of the defect segment.

……………………………............

How do you rate the overall ability of the lung perfusion image set in Figure 6 to represent
2 a planar lung perfusion image set of a patient with suspected pulmonary embolism?

Score
1

2

3

4

5

o

o

o

o

o
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Figure 7

207
Questions – Figure 7

Answer

1 Figure 7 simulates a segmental lung perfusion defect in a patient with suspected
pulmonary embolism. Please specify the name of the defect segment.

……………………………............

How do you rate the overall ability of the lung perfusion image set in Figure 7 to represent
2 a planar lung perfusion image set of a patient with suspected pulmonary embolism?

Score
1

2

3

4

5

o

o

o

o

o
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Figure 8
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Questions – Figure 8

Answer

1 Figure 8 simulates a segmental lung perfusion defect of a patient with suspected
pulmonary embolism. Please specify the name of defect.

……………………………............

How do you rate the overall ability of the lung perfusion image set in Figure 8 to represent
2 a planar lung perfusion image set of a patient with suspected pulmonary embolism?

Score
1

2

3

4

5

o

o

o

o

o
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Appendix B
Lung Perfusion Image Evaluation 2: Reproducibility

Instructions:

1.

This survey was developed to characterise the phantom’s ability to
reproduce the same lung perfusion image sets.

2.

These lung perfusion image sets demonstrate three simulated lung
perfusion defect events of patients suspected of having pulmonary
embolism. All perfusion defects are assumed VQ mismatch defects.

3.

Please score/answer all questions based on criteria given in Table B
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Table B
Score

Image quality

Specification

1

Poor

The results show an inadequate reproducibility standard
of lung perfusion imaging for lung perfusion scan QA
assessment.

2

Average

The results show an acceptable reproducibility standard
of lung perfusion imaging for lung perfusion scan QA
assessment.

3

Satisfactory

The

results

illustrate

an

adequate

reproducibility

standard of lung perfusion imaging for lung perfusion
scan QA assessment.
4

Good

The results show a precise reproducibility standard of
lung perfusion imaging for lung perfusion scan QA
assessment.

5

Excellent

The results show an outstanding reproducibility quality
of lung perfusion imaging for lung perfusion scan QA
assessment.
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Figure 1

213

Score
Question – Figure 1
1

2

3

4

5

o

o

o

o

o

To evaluate reproducibility, three separate scans were obtained
for a given state of lung perfusion. The lung perfusion image sets
are displayed in Figure 1. How do you rate the phantom’s
reproducibility performance?
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Figure 2

215

Score
Question – Figure 2
1

2

3

4

5

o

o

o

o

o

To evaluate reproducibility, three separate scans were obtained
for a given state of lung perfusion. The lung perfusion image sets
are displayed in Figure 2. How do you rate the phantom’s
reproducibility performance?
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Figure 3

217

Score
Question – Figure 3
1

2

3

4

5

o

o

o

o

o

To evaluate reproducibility, three separate scans were obtained
for a given state of lung perfusion. The lung perfusion image sets
are displayed in Figure 3. How do you rate the phantom’s
reproducibility performance?
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Appendix C
Lung Perfusion Image Blind Test 1: VQ mismatch defect size
1. This test was developed to identify Nuclear Medical Physician accuracy in
identifying percentage (size) of perfusion/ventilation VQ mismatch of planar
lung perfusion images.
2. The percentage of VQ mismatch in a planar lung perfusion images is crucial
to identify the probability of pulmonary embolism according to the revised
PIOPED criteria.1 Incorrect identification of VQ mismatch defects’ size leads
to misdiagnosis of planar lung perfusion images for pulmonary embolism
diagnosis.
3. According to the revised PIOPED criteria, I. small VQ mismatch = less than
25% segmental VQ mismatch, ii. Moderate VQ mismatch = 25-75%
segmental VQ mismatch and iii. Large VQ mismatch = more than 75%
segmental VQ mismatch.
4. Please categorise the mismatch defects’ size based on the revised PIOPED
criteria given in the table on the next page.
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The revised PIOPED criteria: 1
High probability

≥ 2 large VQ mismatches
or
1 large VQ and ≥2 moderate mismatches
or
≥ 4 moderate VQ mismatches

Intermediate

1 large ± 1 moderate VQ mismatch

probability

or
1-3 moderate VQ mismatches
or
Difficult to categorize as low or high

Low probability

≥ 1 perfusion defect with smaller chest radiograph defect
in region of perfusion defect
or
Perfusion defects due to pleural effusion, cardiomegaly,
enlarged

aorta,

hilum,

mediastinum

and

elevated

diaphragm.
or
≥ 1 small perfusion defect with normal chest radiograph
or
≥ 2 VQ matches with normal chest radiograph
Normal probability

No perfusion defect. Perfusion outline exactly the shape of
the lung as seen on the chest radiograph.

1Gottschalk

A, Sostman HD, Coleman RE et al. Ventilation-perfusion scintigraphy in

the PIOPED study. Part II. Evaluation of the scintigraphic criteria and
interpretations. J Nuc Med 1993; 34: 1119-1126
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Question 1

VQ mismatch defect size
Question Figure 1
Small

Moderate

Large

(size < 25%)

(25% < size < 75%)

(size ≥ 25%)

o

o

o

Please specify the VQ mismatch
defect size in the lung perfusion
images in Figure 1 based on the
revised PIOPED criteria.
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Question 2

VQ mismatch defect size
Question – Figure 2

Small

Moderate

Large

(size < 25%)

(25% < size < 75%)

(size ≥ 25%)

o

o

o

Please specify the VQ mismatch
defect size in the lung perfusion
images in Figure 2 based on the
revised PIOPED criteria.
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Question 3

VQ mismatch defect size
Question – Figure 3

Small

Moderate

Large

(size < 25%)

(25% < size < 75%)

(size ≥ 25%)

o

o

o

Please specify the VQ mismatch
defect size in the lung perfusion
images in Figure 3 based on the
revised PIOPED criteria.
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Question 4

VQ mismatch defect size
Question – Figure 4

Small

Moderate

Large

(size < 25%)

(25% < size < 75%)

(size ≥ 25%)

o

o

o

Please specify the VQ mismatch
defect size in the lung perfusion
images in Figure 4 based on the
revised PIOPED criteria.
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Question 5

VQ mismatch defect size
Question – Figure 5

Small

Moderate

Large

(size < 25%)

(25% < size < 75%)

(size ≥ 25%)

o

o

o

Please specify the VQ mismatch
defect size in the lung perfusion
images in Figure 5 based on the
revised PIOPED criteria.
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Question 6

VQ mismatch defect size
Question – Figure 6

Small

Moderate

Large

(size < 25%)

(25% < size < 75%)

(size ≥ 25%)

o

o

o

Please specify the VQ mismatch
defect size in the lung perfusion
images in Figure 6 based on the
revised PIOPED criteria.
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Appendix D
Lung Perfusion Image Blind Test 2: Probability of Pulmonary Embolism
Instructions:

1.

This test was developed to evaluate and compare lung perfusion scan
interpretation by a Nuclear Medicine Physician.

2.

The lung perfusion image sets demonstrate six simulated lung perfusion defect
events of patients suspected of having pulmonary embolism. All perfusion defects
are assumed to be mismatch defects.

3.

Please fill in the answer sheet provided based on the revised PIOPED criteria
given in the table below.
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PIOPED revised criteria.1
High probability

≥ 2 large VQ mismatches
or
1 large VQ and ≥2 moderate mismatches
or
≥ 4 moderate VQ mismatches
1 large ± 1 moderate VQ mismatch
or
1-3 moderate VQ mismatches
or
Difficult to categorize as low or high
≥ 1 perfusion defect with smaller chest radiograph defect
in region of perfusion defect
or
Perfusion defects due to pleural effusion, cardiomegaly,
enlarged aorta, hilum, mediastinum and elevated
diaphragm.
or
≥ 1 small perfusion defect with normal chest radiograph
or

Intermediate
probability

Low probability

≥ 2 VQ matches with normal chest radiograph
Normal probability

No perfusion defect. Perfusion outline exactly the shape of
the lung as seen on the chest radiograph.
1Gottschalk A, Sostman HD, Coleman RE et al. Ventilation-perfusion scintigraphy in the
PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations. J Nuc
Med 1993; 34: 1119-1126

Definitions:
VQ mismatch

= normal ventilation and normal chest radiograph in region of
perfusion defect
or
perfusion is more than ventilation/chest radiograph in region of
perfusion defect

small VQ mismatch
moderate VQ mismatch
large VQ mismatch

= less than 25% segmental VQ mismatch
= 25-75% segmental VQ mismatch
≥ 75% segmental VQ mismatch
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Figure C1

Probability
Question – Figure C1
High Intermediate

Low

Normal

o

o

Please specify the probability of PE in the
lung perfusion images in Figure C1 based

o

o

on the revised PIOPED criteria.

Please specify the reason for your answer
………………………………………………………………………………………………………
………………………………………………………………………………………………………
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Figure C2

Probability
Question – Figure C2
High Intermediate

Low

Normal

o

o

Please specify the probability of PE in the
lung perfusion images in Figure C2 based

o

o

on the revised PIOPED criteria.

Please specify the reason for your answer
………………………………………………………………………………………………………
………………………………………………………………………………………………………
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Figure C3

Probability
Question – Figure C3
High Intermediate

Low

Normal

o

o

Please specify the probability of PE in the
lung perfusion images in Figure C3 based

o

o

on the revised PIOPED criteria.

Please specify the reason for your answer
………………………………………………………………………………………………………
………………………………………………………………………………………………………
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Figure C4

Probability
Question – Figure C4
High Intermediate

Low

Normal

o

o

Please specify the probability of PE in the
lung perfusion images in Figure C4 based

o

o

on the revised PIOPED criteria.

Please specify the reason for your answer
………………………………………………………………………………………………………
………………………………………………………………………………………………………
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Figure C5

Probability
Question – Figure C5
High Intermediate

Low

Normal

o

o

Please specify the probability of PE in the
lung perfusion images in Figure C5 based

o

o

on the revised PIOPED criteria.

Please specify the reason for your answer
…………………………………………………………………………………………
…………………………………………………………………………………………
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Figure C6

Probability
Question – Figure C6
High Intermediate

Low

Normal

o

o

Please specify the probability of PE in the
lung perfusion images in Figure C6 based

o

o

on the revised PIOPED criteria.

Please specify the reason for your answer
…………………………………………………………………………………………
…………………………………………………………………………………………
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Appendix E
Lung Perfusion Image Evaluation 3 - Lung scintigraphy atlas
Introduction and instructions:
1.

This survey contains questions related to a lung scintigraphy atlas for pulmonary embolism (PE) diagnosis. The
atlas was developed to be introduced as an aiding material whilst interpreting lung V/Q scans in diagnosing PE.

2.

In this study, an anthropomorphical lung phantom with 18 separable lung segments manufactured at the
University of Wollongong, NSW was used to simulate lung perfusion scans. Planar and SPECT images of single
segmental perfusion defects depict in lung perfusion scans were simulated for all 18 bronchopulmonary segments of
the human lungs. All planar and SPECT image sets were combined to create the lung scintigraphic atlas.

3.

In this study, 8 of the left lung and 10 of the right lung bronchopulmonary segments perfusion deficiencies were
simulated via planar and SPECT imaging. The simulation images are shown in Figure 1-18. The whole simulated
images (Figure 1-18) are named as a lung scintigraphy atlas. The atlas represents perfusion segmental defects of
each bronchopulmonary segment of the human lungs.

4.

Please answer the following questions based on your experience as a nuclear medicine physician.
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LUNG SCINTIGRAPHY ATLAS

Figure 1-18: Simulated lung perfusion planar (top) and selected SPECT (bottom) images of the lung bronchopulmonary segments. All
defects are presumed mismatch defects. The defects are large in size (100% of a segment according to the revised PIOPED criteria).

236

[Figure 1]
Planar and SPECT images of a perfusion defect involving the
apical and posterior segment of the left lung.

[Figure 2]
Planar and SPECT images of a perfusion defect involving the
anterior segment of the left lung.

237

[Figure 3]

[Figure 4]

Planar and SPECT images of a perfusion defect involving the

Planar and SPECT images of a perfusion defect involving the

lingular superior segment of the left lung.

lingular inferior segment of the left lung.
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[Figure 5]

[Figure 6]

Planar and SPECT images of a perfusion defect involving the

Planar and SPECT images of a perfusion defect involving the

superior segment of the left lung.

medial and anterior basal segment of the left lung.

239

[Figure 7]
Planar and SPECT images of a perfusion defect involving the
lateral basal segment of the left lung.

[Figure 8]
Planar and SPECT images of a perfusion defect involving the
posterior basal segment of the left lung.

240

[Figure 9]
Planar and SPECT images of a perfusion defect involving the
apical segment of the right lung.

[Figure 10]
Planar and SPECT images of a perfusion defect involving the
posterior segment of the right lung.
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[Figure 11]

[Figure12]

Planar and SPECT images of a perfusion defect involving the

Planar and SPECT images of perfusion defect involving the

anterior segment of the right lung.

lateral segment of the right lung.
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[Figure 13]

[Figure 14]

Planar and SPECT images of a perfusion defect involving the

Planar and SPECT images of a perfusion defect involving the

medial segment of the right lung.

superior segment of the right lung.
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[Figure 15]
Planar and SPECT images of a perfusion defect involving the
medial basal segment of the right lung.

[Figure 16]
Planar and SPECT images of a perfusion defect involving the
anterior basal segment of the right lung.
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[Figure 17]

[Figure 18]

Planar and SPECT images of a perfusion defect involving the

Planar and SPECT images of a perfusion defect involving the

lateral basal segment of the right lung.

posterior basal segment of the right lung.
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Please score/answer the following questions based on criteria given in the following table.

Score

Image quality

Specification

1

Poor

Not adequate for clinical application.

2

Average

Barely adequate for limited clinical application.

3

Good

Adequate for clinical application.

4

Excellent

Excellent for clinical application.
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Questions
1

As an experienced Nuclear Medicine Physician, how do you rate the atlas’ suitability to be

1
o

Score
2
3
o
o

4
o

o

o

o

o

o

o

o

o

used as a reference resource and teaching aid for new Nuclear Medicine physicians to
develop experience in interpreting lung V/Q mismatch defects for pulmonary embolism
diagnosis?
2

What is your opinion on the atlas’ suitability to be used as a reference (a reference
material to experienced Nuclear Medicine physicians) for anatomical bronchopulmonary
segmental size and structure (scintigraphic and tomographic) in pulmonary embolism
diagnosis by lung perfusion and ventilation scans?

3

What is your opinion on the atlas as an aid to interpret lung perfusion and ventilation
scans for pulmonary embolism diagnosis? We propose Nuclear Medicine physicians use
the atlas as an aid together with standard interpretation criteria (the revised PIOPED
criteria, the Hull criteria or the Gestalt interpretation).

